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1. Introduction 
1.1. Fluorescence spectroscopy in l ife science 
Luminescent techniques are among the fastest-growing analytical tools in life 
science and analytical chemistry. The potential of this techniques are the easy 
automated luminescence monitoring in accordance with their high sensitivity 
and selectivity. This, in turn, has increased the commercial availability of 
fluorescent probes during the last decade[1].  
Fluorescence spectroscopy allows the measurement of numerous 
parameters. These include fluorescence intensity, quantum yield, fluorescence 
polarization, quenching efficiency,  radiative and non-radiative energy transfer 
as well as combinations of these techniques. Measurements can be 
performed in solid, liquid or gaseous phases. Beside the traditional acquisition 
of convential spectra of samples in cuvettes, fluorescence is applied to  
microscopy and imaging, fluorescence energy transfer (FRET) and single 
molecule detection. New dyes are steadily developed for labeling biomolecules. 
Most biomolecules are non-fluorescent or show fluorescence in the UV region. 
The new probes are fluorescent in the visible or NIR region, can be attached 
to, or intercalate in, biomolecules and are excitable by affordable lasers.  
1.2. Labels and probes  
Dyes for bioanalytical applications can be classified into labels and probes. 
Labels are dyes covalently attached to a non-fluorescent biomolecule 
rendering them fluorescent. Recent advances in gene technology have led to a 
great interest in labels for DNA and RNA, respectively. Nucleic acids are non-
fluorescent in the visible region and therefore labels are needed to visualize 
the nucleic acid. To achieve this goal, nucleic acids have to be modified with 
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amino or thiol groups for the attachment of the label, which carries reactive 
groups such as an isothiocyanate or an NHS ester. An other approach is the 
use of a phosphoramidite dye as label, offering the opportunity to attach the 
phosphoramidite dyes directly to a nucleic acid without any modification of the 
DNA/RNA. A brief description of the mechanism is presented in figure 1-1. 
Labeled DNA can be employed for separation techniques like liquid 
chromatography or electrophoresis. In numerous applications the dyes are 
also attached to proteins for fluorescence immunoassays. 
 
 
            Fig. 1-1. Coupling of a phophoramidite dye to an oligonucleotide. 
 
Probes in contrast to labels are used to report the micro-environment 
of a chemical species or structural unit. Usually, the micro-environment of 
membranes or living cells are investigated in terms of viscosity, ion strength, 
pH or cell dynamics. Therefore,  fluorescent probes are needed enabling to 
convert the respective information of a cell into dye specific behaviors like 
fluorescence intensity, life time or changes in its potential sensitivity. In 
contrast to labels, probes do not possess a reactive group. Furthermore, 
membrane probes contain side chains or tails rendering the fluorophore 
soluble in living cells or membranes.  
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1.3. Methods and applications using luminescent dyes in life  
         science  
1.3.1. Electrophoresis in DNA sequencing 
Capillary electrophoresis has become the most valuable tool for the high 
speed and efficient separation of such analytes as pharmaceuticals [2], 
oligonucleotides [3] and proteins [4]. The popularity of CE results preliminarily 
from the high speed at which separation can be carried out as well as the 
high efficiency in separation of even minute quantities. The speed of 
separation is produced by using high electric fields. In many CE application one 
would potentially like to detect several types of labeling dyes, with each dye 
targeted for a specific analyte (multiplex assays). For example in DNA 
sequencing, one generates a series of fragments, which differ in the number 
of bases and are terminated by a common nucleotide base. These are then 
fractionated in a capillary gel column according to size. Since the DNA is 
composed of four bases, it becomes advantageous to identify the four bases 
in a single CE run to improve throughput. This is commonly done using 
spectral discrimination in which each dye has a unique emission maximum and 
the color is sorted using filter systems onto the appropriate read-out 
channel. 
 The fluorophores first developed for CE as labeled primer sequence 
did not have high molar absorbances at a single common excitation 
wavelength [5]. To compensate this deficiency, many CE sequencing detection 
systems used either two excitation wavelengths [6] or alternative base-
coding strategies [7]. The most powerful solution to overcome this problem 
was provided by improved fluorescent labels. Energy transfer (ET) primers 
have been developed that overcome this limitation in a simple and elegant 
manner [8]. These primers contain a common donor dye at the 5´ end and an 
acceptor dye approximately 8-10 nucleotides away. The presence of the 
common donor fluorophore allows the use of a single laser at 488 nm to 
efficiently excitate the donor. The excitation is non-radiatively transferred by 
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resonance ET to the acceptor dye, and therefore the observed emission is 
that of the acceptor. In commercially available ET primers, a fluorescein 
derivative is used as the donor and a rhodamine derivative as the acceptor 
(see figure 1-2). Recently, the advantage of cyanine dyes in ET primers has 
been demonstrated. The advantage of cyanine dyes [9] compared to 
fluorescein dyes is the high molar absorbance along with absorption and 
emission maxima in the near-infrared. As a result a lowered detection limit is 
obtained and therefore spectral cross talks are reduced.  
 
    
5´-GTTTTCCCCAGT*CACGACG-3´
Fluorescein Rhodamine
Excitation
488 nm
Emission
555 nm
Energy transfer
 
 
Fig. 1-2. Schematic of energy transfer primers for capillary electrophoresis. 
1.3.2. Flow cytometry  
Flow cytometry is a technique for carrying out rapid measurements on 
particles or cells as they flow one by one in a fluid stream through the 
detector. Flow cytometers enable multiparameter measurements of individual 
cells. They allow the quantitative measurement of up to 16 parameters of 
each cell at rates of several thousand cells per second. These measurements 
are made separately for each particle within a suspension. This is a main 
advantage of that technique with respect to other methods. Nowadays, flow 
cytometers are available with laser- and arc-lamps enabling the measurement 
of multiple cellular parameters based on light scatter and fluorescence. This 
makes flow cytometry a routine technique in immunology to evaluate, for 
example, three immuno-fluorescence parameters and two light scattering 
effects for each cell [10].  
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 The evaluation of single cells plus sensitive analysis of a large variety 
of cellular molecules are possible with the fluorescence technique, 
accomplished with specific fluorescent labels and probes. Multi parametric 
measurements require a wide range of fluorescent dyes with individual 
emission characteristics. A broad range of probes and labels are commercially 
available. Parameters such as nucleic acid content, enzyme activity, 
membrane potential or pH can be estimated directly [11].  
1.3.3. Fluoroimmunoassays 
Immunoassays are indispensable tools in clinical and analytical biochemistry. 
The relevance is still increasing due to their outstanding specificity and 
sensitivity. Possibility of extending them to a nearly unlimited number of 
analytes and their adaptability to automation make them to an ideal tool for 
routine assays. Hence, immunoassays became centrally important in the 
analysis of drugs, pesticides, hormones and proteins. Immunological methods 
are based on the competitive binding of labeled and unlabeled antigens to 
highly specific antibody receptor sites. Fluorescent labels may be bound to 
antigens or antibodies. Specific determination of the signal corresponding to 
either labeled or unlabeled analyte can be achieved in two ways, the 
heterogeneous and the homogeneous immunoassay. 
Heterogeneous and homogeneous immunoassays 
The heterogeneous immunoassay requires physical separation of labeled 
analyte from label-free analyte. This separation avoids endogenous background 
interference and achieves low detection limits. Therefore, analyte or antibody 
are attached to a solid surface. The reactant distribution of the liquid phase 
and the solid phase are followed by physical separation of these phases 
[12, 13]. Homogeneous fluorescent immunoassays do not require any 
separation of labeled antigens from free-labeled antigens. In fact, the number 
of procedural steps is reduced decreasing time requirements and avoiding 
sample loss through transfer processes [14]. 
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Labels for immunoassays 
To minimize the effect of non-specific background, labels should have high 
fluorescence quantum yields along with an excitation and emission maximum 
at longer wavelengths. The absorption mamima are expected to be longer than 
those typically shown by proteins (280 and 340 nm). The most widely used 
fluorescent labels in immunoassays are derivatives of fluorescein 
isothiocyanate (FITC). Their advantages are highly molar absorbencies and 
quantum yields. However, the Stokes’ shift of FITC is small. Alternative probes 
show specific advantages compared to FITC. For example, rhodamine B 
isothiocyanate conjugates have excitation and emission maxima at 550 / 
585 nm and an increased quantum yield. To overcome limitations caused by 
autofluorescence of biological samples, new red and near infra-red dyes (NIR) 
were introduced [15, 16] providing emission maxima between 600 and 
800 nm. 
1.4. Applications of metal - ligand complexes in life science 
During the last years metal-ligand complexes (MLCs) have become important 
in biophysics and clinical chemistry, because they display a wide range of 
absorption and emission wavelengths and their decay times range from 
100 ns to 100 µs. Optimally tailored MLCs can be obtained by careful 
selection of the metal and the ligand. For instance, lifetimes as long as 
100 µs can be obtained using rhenium as the metal ion in such complexes. 
Rhenium complexes display also good quantum yields and high initial 
polarizations in aqueous solutions. Absorption wavelengths of 460 nm and 
700 nm can be obtained using osmium and ruthenium in MLCs, respectively. 
In clinical routine analysis the excitation with a 488 nm argon ion laser is a 
common tool, which offers many applications for ruthenium complexes in 
clinical chemistry.  
 
Recently, these complexes have been developed as luminescent probes 
for immunoassays [17-20]. The polarized emission combined with a lifetime in 
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the microsecond range offers the possibility to study processes like the 
rotation of proteins or other macromolecules. MLC labels are often used in 
fluorescence microscopy [21-24]. The combination of temporal and spectral 
resolution in fluorescence microscopy based on MLC labels offers also an 
increase in resolution and probe selectivity. This effect is based on the 
suppression of scattered light and short-lived autofluorescence of the sample. 
The use of ruthenium complexes instead of the most commonly used ethidium 
bromide in DNA analysis was reprted [25]. The complex luminescence is 
increasing when intercalating the probe into the double strand of a DNA. The 
oxygen sensitivity of ruthenium complexes with 4,7-diphenyl-1,10-
phenanthroline as ligand is used for measuring oxygen routinely [26, 27]. Also, 
lifetime-based optical sensors for pH [28, 29], chloride [30], carbon dioxide 
[31] and potassium [32] were presented recently using ruthenium complexes.  
1.5. Objective of the work 
The aim of this work was to synthesize new dyes useful for labeling proteins 
and DNA oligomers. The work also focused on the development of dyes for 
membrane characterization. In contrast to available luminophores, these dyes 
should fulfill the criterion of being excitable with an 488 nm argon ion laser 
used in clinical routine analysis. In a further approach, unsymmetrical MLC 
luminophores, which exhibit lifetimes in the hundred nanosecond range, were 
designed.  
 In this thesis, ruthenium MLC and fluorescein membrane probes 
were also synthesized and characterized for measuring membrane dynamics. 
The optimal membrane probe was evaluated using the method of steady-state 
polarization. Varying luminophore, ligand and lipid systems were tested in 
DPPC liposomes for its temperature and cholesterol sensitivity to 
polarization. 
 Furthermore, this thesis presents the development of an assay for 
HSA/anti-HSA using the principle of energy transfer. A ruthenium MLC was 
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used as donor and a squarine dye as acceptor. The energy transfer assay was 
developed in terms of emission intensity and lifetime. Additionally, a DNA 
hybridization system was evaluated with the same donor and acceptor pair 
used for the protein assay.   
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2. Background 
 
 
In this chapter an introduction is given to the methods used in this thesis. 
The theories of lifetime, fluorescence resonance energy transfer and steady-
state f luorescence polarization are explained. Addit ional ly, a brief ly 
descript ion of the way of measurement for each method is  presented.  
 
 
2.1. Lifetime  
2.1.1. Theory  
The fluorescence lifetime of a substance indicates the average time a molecule 
remains in the excited state before it returns into the ground state [1, 2]. In 
case of a single-exponential decay, the lifetime (decay time)  t is defined as the 
time after which the fraction of 1/e of the excited molecules still exists in the 
excited state. 
Lifetime measurements are frequently necessary in fluorescence 
spectroscopy. The measurement of the fluorescence lifetime rather than 
fluorescence intensities allows the elimination of several drawbacks known 
from intensity measurements. The lifetime is independent of signal 
fluctuations of the light source and the photo detector. In contrast to other 
methods there are no drifts occurring from photobleaching, 
photodecomposition or leaching. The concentration of the indicator dye has 
also no effect on the lifetime provided that the signal to noise ratio is 
sufficiently high. Especially in case of dynamic quenching from oxygen, the 
measurement of the luminescence lifetime is a well established technique 
[3-5]. 
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There are two widely used methods for the measurement of fluorescence 
lifetime: The pulse (or time domain) method and the phase modulation (or 
frequency domain) method [1]. In the pulse method the luminophore is excited 
with a short pulse of light and the time dependent decay of fluorescence 
intensity is measured. In the phase-modulation method the luminophore is 
excited with sinusoidally modulated light. The lifetime of the fluorophore 
causes a time lag between absorption and emission, expressed by the phase 
shift f and a decrease in emission intensity relative to the incident light, 
called demodulation (dm) (figure 2-1).  
 
 
Fig. 2-1. Schematic description of the frequency domain 
method. The sinusoidally modulation light is shifted (f) and 
demodulated (dm). 
 
The loss of intensity in the emission relative to the excitation is 
described by the demodulation. The amplitude (B/A) of the emission is smaller 
than the amplitude of the excitation. The phase delay f and the demodulation 
dm can be separately used to calculate the lifetime (eq. 2-1 and 2-2) of the 
fluorophore [1].  
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 fwt tan1 ×= -p   (2-1) 
 2
1
21 ]1)/1[( -×= - dmdm wt  (2-2) 
with w = 2 ·  p ·  f. 
However, the assumption that tp=tdm=t is only valid for a single 
exponential decay. Otherwise, the calculated lifetimes are apparent values 
only,  and the lifetime measurement is more complicated. 
In practice, the phase modulation technique is a very attractive 
analytical tool. In contrast to other detection methods (i.e. absorptiometry, 
fluorimetry) it shows increased accuracy. The instrumentation used is rather 
simple that light emitting diodes (LED) can serve as excitation light source, 
photodiodes or photomultiplier tubes (PMT) for detection of the emitted light, 
suitable excitation and emission filters and a lock-in amplifier. Moreover, 
electronical cross talks and ambient light have little effect on the signal 
obtained. 
Frequency domain decay time measurements can be performed in the ns 
and ps range. For short lifetimes, modulation frequencies in the upper MHz 
range are required and therefore the equipment is rather expensive.  
2.1.2. Method of measurement 
Lifetime measurements were carried out on a ISS K2 multifrequency phase 
modulation fluorometer using an argon ion laser as the excitation source and 
two signal generators. The light was passed through a Pockels cell which 
provides modulated light. Emission was detected perpendicular to the 
excitation through a 610-nm filter. Lifetimes were referenced against a dilute 
suspension of glycogen. Each measurement was carried out at ten modulation 
frequencies (logarithmically spread from 50 to 1500 kHz).  The lifetime was 
calculated with the respective software of the instrument.   
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2.2. Fluorescence resonance energy transfer (FRET)  
FRET is a distance-dependent non-radiant energy transfer of excited state 
energy from a donor to an acceptor and arising from dipole-dipole interactions 
between the donor and acceptor molecule. Non-radiative energy transfer does 
non involve the emission and re-absorption of photons. A transfer, where the 
acceptor dye reabsorbs photons emitted by the donor is called radiative 
transfer or inner filter effect [1]. The rate of non-radiative energy transfer (kT) 
depends on the fluorescence quantum yield of the donor, the overlap of the 
emission spectrum of the donor with the absorption spectrum of the 
acceptor, and their relative orientation and distance. The theory was 
developed by Förster [6], who derived the quantitative expression of kT 
between a donor and acceptor pair at a fixed separation distance r (eq. 2-3).  
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where k2 is a factor describing the relative orientation in space of the 
transition dipoles of the donor and acceptor, fd and td are the quantum yield 
and lifetime of the donor in absence of the acceptor, r is the distance 
between donor and acceptor and n is the refractive index. J is the overlap 
integral (eq. 2-4), which expresses the degree of spectral overlap between 
the donor emission and the acceptor absorption. J depends on FD(l), the 
corrected fluorescence intensity of the donor in the wavelength range l + dl, 
with the total intensity normalized to unity, and eA(l) the acceptor extinction 
coefficient at the wavelength l. Eq. 2-3 shows that kT is dependent on  the 
sixth power of the intermolecular distance, thus making FRET an interesting 
tool  for monitoring distances between donor and acceptor labeled targets like 
biological macromolecules [7, 8]. 
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 Energy transfer measurements were carried out by using the 
measurement methods of fluorescence intensity and lifetime. Energy transfer 
from the donor to the acceptor will quench the fluorescence and alter both 
the fluorescence intensity and lifetime. The advantage of an energy transfer 
system based on lifetime measurement is the conversion of an emission based 
signal into an intensity independent decay time signal.  
 A ruthenium metal ligand complex with 2, 2´-bipyridine as ligand was 
used as the donor. This ligand is less susceptible to oxygen quenching than for 
example the phenanthroline ligands. Additionally, the lifetime in the hundreds 
of  nanoseconds region simplifies the instrumentation needed for lifetime 
measurements.  
2.3. Steady -state fluorescence polarization  
2.3.1. Theory [1] 
Since the absorption and the emission of light depend on the orientation of 
the transition dipole moments, the introduction of vertically polarized 
excitation light can provide information on the rotational motion of the 
fluorophore. After distribution of excited fluorophores, the excited 
fluorophores are able to relax to an uniform random set. This process can be 
traced in order to determine the rotational motion of fluorophores by 
measuring the state of emission anisotropy with time. This can generally be 
described as a multiexponential decay given by 
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)()(
)(      (2-5) 
 
where r(t) is the anisotropy at the time t after excitation and r0 is the limiting 
anisotropy in the absence of rotational diffusion. Maximum values for r0 are 
observed when the absorption and emission dipol moments are collinear 
(rmax,0=0.4). The subscripts of I(t) indicate the relative orientation, parallel (II) 
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and perpendicular (^ ), of the polarizers, respectively (see figure 2-2). qi are the 
individual rotational correlation times, and fi are the associated fractional 
amplitudes (å =
i
if 1 ). The extend of depolarization of the emission of the 
fluorophore in a biomolecule reflects the degree to which a population of 
photoselected excited fluorophores loses its initial selective orientation and 
becomes randomized. 
Anisotropy  (r) and polarization (P) are related by 
^
^
+
-
=
II
II
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II
II        (2-6) 
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      (2-7) 
where III and I^ are the vertically and horizontally polarized components of the 
emission. 
 
Fig. 2-2. Schematic description of the L- format measurement of 
the II I and I^ component for polarization and anisotropy 
determination. 
 
The values of P and r can be converted into each other according to eq. 2-8 
and eq. 2-9 
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      (2-9) 
2.3.2. Method of measurement 
Steady-state polarization measurements were carried out with an ISS K2 
multi-frequency phase modulation fluorometer. The instrument was aligned to 
the L-format light path and equipped with polarizers, and a xenon lamp as the 
excitation light source.  The excitation wavelength was adjusted to 488 nm 
and a 610 nm long-pass filter was placed in the emission light path to 
separate stray light. The steady-state polarization P was calculated [8] 
according to: 
   
 
VHVV
VHVV
GII
GII
P
+
-
=  (2-10) 
 
where G is the instrumental correction factor (G = IHV/IHH), IVV the emission 
intensity at vertically polarized excitation and emission filters, and IVH the 
emission intensity at vertically polarized excitation and horizontally polarized 
emission filters. The temperature was controlled at a constant temperature 
of 25 °C by a circulating thermostated water bath connected to the sample 
cell. The ISS instrument used for steady-state polarization measurement is 
illustrated in figure 2-3. 
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Fig. 2-3. Schematic illustration of the ISS K2 multifrequency phase 
modulation fluorimeter aligned for polarization measurements.  
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3. Syntheses and Spectral Characterization 
 
 
In this chapter, the synthesis and characterization of two labels  are 
presented. They can be both covalently conjugated to HSA, anti-HSA and 
DNA. Furthermore, the syntheses of ruthenium MLC and fluorescein 
membrane probes is introduced. 
 
3.1. Labels 
3.1.1. The mono-react ive ruthenium metal - l igand complex Ru-1 
Synthesis 
Luminescent probes covalently linked to biological macromolecules are of 
widespread interest for basic studies such as characterizing biologically 
relevant energy- and electron-transfer reactions and for clinical applications 
such as detecting proteins and deoxyribonucleic acids (DNA) [1-4]. Probes like 
metal-ligand complexes known for a number of favorable properties for these 
puposes including (a) reversible electrochemical behavior, (b) photochemical 
stability, (c) energetic excited states and (d) long lifetimes in solution (see 
figure 3-1). Furthermore, such chromophores are widely used to study a 
number of photophysical processes including energy-transfer and electron-
transfer reactions in supramolecular inorganic assemblies [5, 6] and biological 
systems [7]. For investigating protein and DNA systems, the mono-reactive 
ruthenium MLC Ru-(bipy)2-(mcbpy) Ru-1 was synthesized and activated to the 
corresponding NHS ester.  
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            Fig. 3-1. Properties of metal ligand complexes. 
 
The synthetic pathway of  the activated NHS ester of Ru-1 is shown in 
figure 3-2. The corresponding methyl derivatives are potentially useful 
precursors for carboxy compounds. Therefore, the mono-reactive ligand 
4,4´-dimethyl-2,2´-bipyridine (1) was selectively oxidized to afford the  
4´-mono-carbaldehyde derivative (2), using selenium dioxide as oxidizing 
reagent [8]. The carbaldehyde obtained was oxidized with AgNO3 to the 
carboxylic acid (3) in a yield of 75% [9]. The coupling of the third ligand (3) to 
Ru(bipy)2· 2H2O was performed in an ethanol:water mixture (7:3, v/v) saturated 
with NaHCO3. The reaction was carried out under reflux heating and the 
reaction time was set to 12 h. The active NHS ester of Ru-1-NHS was 
prepared by reacting N-hydroxysuccinimide/DCC with the carboxylic acid Ru-1. 
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Fig. 3-2. Synthetic pathway to the Ru-1-NHS ester. 
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Characterization of Ru-1 
The spectroscopic properties of Ru-1 are presented in figure 3-3. Ru-1 
exhibits the characteristic metal-to-ligand charge-transfer band (MLCT), 
centered at 456 nm in the absorption spectrum.  The same is found for 
Ru(bipy)32+. The p-p* transition of bipyridine is present at 280 nm. Excitation 
of the MLCT band at 450 nm results in an emission with a  maximum at 
612 nm in (phosphate buffer). Under these conditions the emission lifetime of 
Ru-1 is 329 ns. 
 
Fig. 3-3. Absorption  (straight line) and emission spectra (dotted line) of Ru-1 
in PBS. 
 
Sensitivity to oxygen 
An investigation on the effect of oxygen on the fluorescence intensity and 
lifetime of the free and protein bound form was performed, when measuring 
the behavior of Ru-1 and Ru-1/HSA either in air-equilibrated solutions or 
saturated with argon. The results are depicted in table 3-1. As compared to 
the deoxygenated solutions, the relative fluorescence intensities of Ru-1 and 
Ru-1/HSA in air-equilibrated buffer solutions are 0.79 and 0.91, respectively. 
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The intensity of the free ruthenium complex is more sensitive to dissolved 
oxygen than the protein bound species. The lifetime measurements are in 
accordance with the obtained fluorescence intensity data. The results show 
that the sensitivity of the protein bound form is modest and do not require 
elimination of oxygen. 
Table 3-1. Sensitivity of Ru-1 (in PBS and when covalently bound to HSA) to  
 oxygen in terms of emission intensity and lifetime. 
Ru-1 Ru-1/HSA  
air argon air argon 
    rel. emission 
intensity 0,79 1 0,91 1 
     
395 517 488 512 lifetime (ns) 
    
 
 
3.1.2. The mono-react ive dye RB-631 
Choice of label 
The synthesis of unsymmetrical squarylium dyes has been demonstrated by 
Oswald et al. [10]. The advantage of these unsymmetrical dyes are their 
single reactive site, thus enabling the substance to be labeled only in a molar 
ratio of 1:1. Moreover, the bis-reactive dye can also react in a ratio of 1:2, 
leading to undesired dimers, or conjugates with decreased biological activity. 
Synthesis of RB-631-NHS 
RB-631 was synthesized by analogy to a procedure of Oswald [11]. The 
synthetic pathway is illustrated in figure 3-4. The unsymmetrical squarylium 
dye RB-631 was synthesized in a 4-step reaction (I-IV). A carboxypentyl 
quaternized indole was reacted with the equamolar amount of squaric acid 
dibutyl ester (I). The dibutyl ester instead of the respective free acid has the 
advantage of a lowered reactivity. Thus, a direct synthesis to the symmetrical 
squarylium dye can mostly be avoided. This squaric acid derivative was reacted 
with a second indole, an ethyl quarternized one (II). The substitution of 
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hydrogen by an ethyl group at the indole nitrogen makes the dye pH 
insensitive to optical properties, which might appear at dyes having a free 
proton at this position. The long reaction time of 15 h results in the formation 
of the butyl ester, which is purified by MPLC. The butyl ester is hydrolyzed 
with 0.1 N HCl (III). The yield of this reaction is almost quantitative. Thus no 
further purification was necessary at this step. The last step of the synthesis 
is the activation to the NHS ester (IV). The NHS/DCC method was found to be 
the best due to the higher yield of NHS ester, compared to the N,N,N´,N´-
tetramethyl(succinimido)uranium method [11]. 
 
 
Fig. 3-4. Synthetic pathway to the RB-631-NHS ester. 
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Characterization of RB-631 
In figure 3-5, the spectroscopic properties of RB-631 in PBS are shown. 
RB-631 has an absorption maximum at 631 nm and an emission maximum at 
645 nm. The molar absorbance is 95,000 L/(mol· cm) and the quantum yield is 
0.04, using Cy5 as reference standard (QYCY5 = 0.25).  
 
Fig. 3-5. Absorption (straight line) and emission spectra (dotted line) 
of RB-631 in PBS. 
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3.2. Membrane probes 
Fluorescent analogues of naturally occurring lipids are already applied primarily 
as probes of biological membrane structures and as tracer of lipid metabolism 
and transport. These membrane probes are frequently covalently attached to 
fatty acids or phospholipids. Most phospholipids are esters of glycerol 
comprising two fatty acyl residues (nonpolar tails) and a single phosphate 
ester substituent (polar head group). Fluorescent phospholipids analogues can 
be further classified according to the location of the attached fluorophore. A 
fluorophore can be bound either to one of the fatty acyl chains or to the polar 
head group and is situated either in the nonpolar interior or at the water/lipid 
interface. The fluorescent analog is incorporated into a lipid bilayer membrane. 
Fluorescent fatty acids can be substituted by the corresponding phospholipids 
as membrane probe [12]. The fluorescent sterols and cholsteryl esters are 
widely used as structural probes and transport markers for these important 
lipid constituents of membrane and lipid proteins. 
 In this work, phospholipids and fatty acids analogues of the luminescent 
ruthenium metal ligand complexes and the fluorescent fluorescein were 
synthesized and investigated for membrane characterization. All phospholipid 
analogues were covalently attached to the polar head group of the 
phospholipid. Therefore, the amphiphilic membrane probes are located at the 
water lipid interface when incorporated into a lipid bilayer.  
3.2.1. Fluorescein membrane probes 
The reactive NHS-fluorescein was used to link the lipophilic fatty acids and PE 
to the fluorophore. This fluorescein derivative was also used to label proteins 
and other macromolecules containing primary amine groups.  
 NHS-fluorescein is an amine-reactive fluorescent probe that contains a 
carboxysuccinimidyl ester group at position 5 or 6 carbons on fluorescein´s 
lower ring structure [13, 14]. The 5- and 6- isomers are identical in their 
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reactivity and fluorescence characteristics. The spectral properties of NHS-
fluorescein are similar to those of the carboxy compound. The wavelength of 
the absorbance and emission maxima are 491 nm and 518 nm, respectively. 
The molar extinction coefficient is 66 000 mol· L-1· cm-1. 
 The reaction of the membrane probe (figure 3-6) was performed in 
chloroform, due to good solubility of the lipid and the membrane probe 
produced. However, the low solubility of the dye in chloroform required a 
reaction time of 24 h. The crude product was further purified by MPLC. 
 
 
Fig. 3-6. Synthesis of the fluorescein membrane probes 
(PE: 1,2- dipalmitoyl- sn- glycero-3- phosphoethanolamine). 
 
 
O OHO
COOH
N
O
O
O
O
R NH2
CH3Cl
(Et)3N
R= -C16H33
-C18H37
-PE
R
+
O OHO
COOH
O
NH
Chapter 3: Syntheses and Spectral Characterization 
 
page 28 
3.2.2. Ruthenium MLC membrane probes 
Membrane probes of the type Ru-1-R 
Ru-1 was used as initial product for the synthesis of the membrane probes of 
the type Ru-1-R via the NHS/DCC method. The reaction was also carried out 
in chlorofom, because of the good solubility of the membrane probes and the 
lipid. The required analytical grade of the membrane probes was achieved by 
further purification with MPLC. 
 
Fig. 3-7. Synthesis of the membrane probes of the type Ru-1-R 
(PE: 1,2- dipalmitoyl- sn- glycero-3- phosphoethanolamine). 
 
Membrane probes of the type Ru-2-R2 
The membrane probes of the type Ru-2-R2 were synthesized in a 4-step 
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by a simple oxidation step using aqueous chromium(VI)oxide. The yield of  90% 
was surprisingly good for the oxidation with CrO3.  
 The coupling of the third ligand (4) to Ru(bipy)2Cl2· 2H2O was performed 
in a methanol:water mixture (4:1, v/v), saturated with NaHCO3. The reaction 
was carried out by reflux heating for 12 h. 
 First, for the conversion of Ru-2 to the respective membrane probe the 
NHS/DCC method was used with only a 5% yield. To increase the yield of the 
membrane probe an alternative method was found. The activation of the 
dicarboxy compound  Ru-2 was carried out by using the carbodiimide EDC and 
DMAP as catalyst. The reaction mixture was stirred at room temperature in 
chloroform. The enhanced reaction time of 15 h results in the formation of the 
specific membrane probe, which was purified by MPLC. 
 
 
Fig. 3-8. Synthetic pathway to the membrane probes of the type Ru-2-R2 
(PE: 1,2- dipalmitoyl- sn- glycero-3- phosphoethanolamine). 
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3.2.3. Spectral  character izat ion of the membrane probes 
In table 3-2, the absorption and emission maxima as well as the lifetime of 
fluorescein membrane probes are faced with the ruthenium MLC membrane 
probes. The data were recorded in methanol at 25 °C. All fluorescein 
derivatives exhibit the same spectral properties and are similar to those of 
the carboxy compound. The absorption and emission maxima were found at 
497 nm and 520 nm, respectively. The average lifetime of the fluorescein 
membrane probes are about 4 ns.  
 
Table 3-2.  Absorption, emission and lifetime properties of the fluorescein and  
  ruthenium MLC membrane probes. 
membrane probe lmax (abs) lmax (em) t (ns) 
    
Fl-PE 497 520 4 
Fl-C16 497 520 4 
Fl-C18 497 520 4 
    
Ru-1-C16H33 456 635 274 
Ru-1-C18H37 456 635 279 
Ru-1-PE 456 650 345 
Ru-2-PE2 456 665 398 
Ru-2-(C16H33)2 456 655 307 
Ru-2-(C18H38)2 456 655 305 
 
 The major absorption peak of all ruthenium MLC membrane probes is at 
456 nm due to the metal-to-ligand charge transfer (MLCT). The results are 
similar to Ru-1. In contrast to the respective carboxy compound Ru-1, the 
emission maxima of all MLC membrane probes are shifted to higher 
wavelengths (see table 3-2). 
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Fig. 3-9. Emission behavior of the membrane probe Ru-2-(C16H33)2  
for different solvents. 
 
To investigate this effect, the emission maxima of the membrane probe 
Ru-2-(C16H33)2 was measured under different polar conditions (see figure 3-9). 
The emission maximum in methanol was found at 655 nm, while in chloroform 
the emission maxima is at 610 nm. A larger bathochromic shift was observed 
when a higher extend of alkylation of the membrane probe is used. The 
membrane probes with only one lipid anchor like Ru-1-C16 are smaller red-
shifted than the probes of the type Ru-2-R2. This effect is also concerned to 
the different behavior of the membrane probes in different solvent 
environments. 
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4. Membrane Probes 
 
 
Two types of lipophilic analogues of ruthenium metal-ligand complexes (MLC) 
and fluorescein derivatives were synthesized. These probes display polarized 
emission, thus making them viable probes for studying membrane dynamics 
and molecular orientational order. The probes were incorporated into lipid 
bilayers. The temperature-dependent properties of this lipid bilayers were 
investigated in terms of emission intensity, l i fetime and steady-state 
f luorescence polar izat ion. 
 
 
4.1. Introduction 
4.1.1. Membrane v iscosity 
Membrane viscosity, a parameter known to be affected by the structural and 
dynamic properties of cell membranes, is a key parameter in arteriosclerosis 
research. Cholesterol is the main sterol in animal organisms and plays a 
central role in modulating chemical and physical properties [1]. It is present in 
membranes of liver cells and erythrocytes in equimolar concentrations of 
phospholipids. Alterations in the cholesterol content in natural membranes 
are responsible for the membrane viscosity due to significant changes in the 
conformation and amplitude of the motions of the bilayer components [2-3].  
4.1.2. Measuring membrane v iscosity 
Hydrophobic fluorescent molecules have proven to be suitable as probes for 
the characterization of various membrane properties including surface charge, 
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fluidity, lateral diffusion and metabolism of the lipid [4-6]. In studies of model 
and biological membranes, most of the useful probes are derivatives of pyrene 
and 1,6-diphenylhexatriene (DPH) [7]. So far, two methods were used to 
measure membrane viscosity. On the one hand, the excimer formation of 
pyrene decanoic acid (PDA) and on the other hand the fluorescence 
polarization of DPH is used. For both methods, the fluorophore is embedded in 
the membrane of interest. 
Excimer formation of PDA 
It is well known that an excited pyrene molecule in close proximity to a 
molecule remaining in its ground state may form a dimer in an excited singlet 
state (“excimer”) [8]. The fluorescence emitted by the excimer is broad, 
unstructured, and red-shifted with respect to the monomer emission and is 
therefore readily distinguishable and well resolved from it. Since an excimer 
can form only if the excited pyrene molecule becomes a nearest neighbor to 
one in its ground state in a time comparable to the excited state lifetime, the 
relative yields of excimeric and monomeric fluorescence from a pyrene 
containing lipid analogue is a measure of the probes lateral mobility within the 
membrane [9, 10]. 
 
 
Fig. 4-1. Schematic description of the excimer formation in membranes. 
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Fluorescence polarization of DPH 
Diphenylhexatriene and its derivatives are the probes of choice for structure 
and dynamic membrane studies  [11, 12]. There, DPH has been used rather 
often to estimate membrane fluidity [13, 14]. DPH and its derivatives are well 
suited for such experiments because they exhibit a strongly increased 
fluorescence when bound to lipids. Additionally, their fluorescence polarization 
is sensitive to phospholipid orientational order, a parameter used to measure 
membrane viscosity. DPH is incorporated in the lipophilic part of the lipid 
bilayer. The membrane viscosity is measured by fluorescence polarization 
depending on the motion of DPH in the lipid bilayer, which corresponds itself 
to the membrane viscosity.  
 However, the use of PDA and DPH as membrane probes are limited due 
to their need for excitation in the UV, where fluorescence background is 
rather strong in "real" samples, and due to their lifetimes, which is in the 
nanosecond region.  
4.1.3. Phase transit ion of DPPC l iposomes 
Phase transition in liposomes is a characteristic parameter to measure the 
properties and the composition of certain membrane. For our investigation we 
used the phospholipid di-palmitoyl-glycero-phosphatidylcholine (DPPC) for 
liposome preparation. The characteristic phase transition of DPPC occurs at 
41 °C, which is presented in figure 4-2. The steady state fluorescence 
polarization of DPPC in the liquid crystalline phase is significantly lower than 
that in the gel phase, because greater static and dynamic molecular disorder 
is present in the liquid crystalline phase of the bilayer [15-17]. 
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Fig. 4-2. Temperature- dependent polarization of an incorporated dye 
in DPPC liposomes. 
 
4.2. New Membrane Probes 
Probes with absorption and emission at wavelengths in the visible and near-
infrared region are highly desirable, because background luminescence 
decreases strongly with wavelength (as does light scatter). We searched for 
probes excitable by the argon ion laser line (488 nm) and compatible with 
respective instrumentation in clinical research. Therefore, we considered two 
classes of luminophores being preferable for measuring membrane dynamics, 
namely amphiphilic fluorescein and ruthenium metal-ligand complexes, because 
both dye classes exhibit high fluorescence polarization. 
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4.2.1. Fluorescein membrane probes 
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Fig. 4-3. Amphiphilic fluorescein dyes synthesized for membrane probes. 
 
Fluorescein derivatives are the probes of choice for measuring membrane 
dynamics, because they exhibit a high fluorescence polarization of about 0.4. 
However, by employing amphiphilic fluorescein derivatives as membrane probe, 
the small Stokes’ shift of 20 nm arises the problem of separating excitation 
to stray light and emitted light. The lifetimes of these fluorescein derivatives 
are in the nanosecond region similar to that which can be found for DPH.  
 To make the probe amphiphilic, dicarboxyfluorescein was covalently bound 
to hexadecylamine (Fl-C16), octadecylamine (Fl-C18) and 1,2-dipalmitoyl-sn-
glycero-3-phosphoethanolamine (Fl-PE). The chemical structures of the 
synthesized fluorescein membrane probes are illustrated in figure 4-3. 
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4.2.2. Ruthenium MLC membrane probes 
The ruthenium complexes comprise a class of metal-ligand complexes (MLCs) 
that are known to display luminescence if excited with light of 440 to 490 nm. 
Their luminescence exhibits a large Stokes’ shift with a maximum at 610 nm. 
However, all conventional ruthenium MLCs are rather hydrophilic and do not 
incorporate into lipids or lipid membranes. They have to be rendered lipophilic 
by introduction of lipophilic side groups [18]. 
 Ruthenium complexes show a certain advantages in terms of varying the 
characteristics of the membrane probes. Ruthenium membrane probes are  
comprised of three parts, which can affect the properties of the membrane 
probes (figure 4-4). The preliminary compound of the metal- ligand complex 
consists of two ligands, which can be varied. That can be hydrophilic, lipophilic 
and charged ligands influencing the incorporation of the membrane probe in 
the bilayers. The reactive ligand can be chosen as mono- or bisreactive ligand, 
which dispose to the degree of rotational freedom of the dye when 
incorporated in the membrane. Finally, the lipophilic part  of the dye can be 
varied. Adherence of tails with varying chain length of phospholipids or lipids 
influences the depth of incorporation of the dye in the membrane [19]. 
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r
lipid
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of the metal-ligand
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Fig. 4-4. Schematic picture of a ruthenium metal- ligand complex membrane 
probe. 
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 The synthesis of new membrane probes based on a Ru-MLC fluorophore 
covalently bound to lipids and phospholipids is reported here. These amphiphilic 
probes incorporate their non-fluorescent tail into the bilayer, while the 
fluorescent moiety remains partly in the lipid-water interface (figure 4-5).   
 
 
Fig. 4-5. Schematic of the MLC probes incorporated into liposomes 
of DPPC. 
 
 
 When designing the MLC membrane probes, we considered the 
pseudoglyceryl backbone and the C16 and C18 alkyl chains as a suitable 
structural anchor enabling incorporation into bilayers. These types of building 
blocks are ubiquitously present in naturally occurring phospholipids. Especially, 
two kinds of this MLC lipid probes were synthesized. In the first (Ru-1-R), the 
mono-carboxy derivative Ru(bpy)2(mcbpy) is linked to a single lipid moiety. In  
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the second type (Ru-2-R2), the dicarboxy MLC Ru(bpy)2(dcbpy) was linked to 
two lipids. Probes of the kind Ru-1-R were expected to undergo free rotation 
on the membrane surface. For Ru-2-R2, the MLC is linked to two lipid moieties 
and it was expected that this may retard or even prevent free rotation of the 
MLC and thus improves the resolution at comparatively long rotational 
correlation times. The excitation and emission maxima of these complexes are 
at approximately 460 and 640 nm, thus making them compatible with 
commonly used flow cytometers based on a 488-nm excitation source. The 
chemical structures of the ruthenium MLC membrane probes are displayed in 
figure 4-6. 
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Fig. 4-6. Chemical structures  of the ruthenium metal- ligand complex membrane probes. 
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4.3. Methods and Materials 
4.3.1. Mater ia ls 
 DPPC (1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine), PE (1,2-
dipalmitoyl-sn-glycero-3-phosphoethanolamine) and cholesterol were 
purchased from Sigma. All other chemicals were supplied from Fluka and used 
as received. Solvents were from Merck. The water used was double distilled. 
4.3.2. Preparation of Liposomes 
For liposome preparation, aliquots (typically 1 mg of DPPC and an aliquot 
quantity of the lipid probes in a dye to lipid ratio of 1:100) were dissolved in 
2 mL of chloroform and placed in a test tube. This solution was kept in a 
water bath at 55 °C and the solvent was removed by a stream of nitrogen. 
Liposomes were prepared by sonication in a buffer (10 mM Tris and 50 mM 
KCl, pH 7.5) at a final lipid concentration of 1 mg/mL. After vortex-mixing, the 
sample was passed through a polycarbonate filter (100 nm pore size) with an 
extruder (Avestin Lipofast, Avestin, Ottawa, Canada). For visualization the 
colloid liposomes in the lipid mixture were digitalized with a fluorescence 
microscope shortly before the extruding step (figure 4-7). After extruding 
solely a homogeneous red fluorescence was observed when verified with the 
fluorescence microscope. This indicates a liposome size < 100 nm. 
 
 
 
 Fig. 4-7. Ruthenium membrane probes shortly before the extruding  
 step. 
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4.4. Results 
There are certain requirements for membrane probes to be suitable for 
measuring membrane dynamics. The amphiphilic dyes have to display 
polarization in such a way that membrane dynamics can be measured 
according to the DPH method. The polarized emission has to be sensitive to 
the characteristic phase transition temperature of the liposomes, where the 
dye is embedded. After all, the membrane probes has to show cholesterol-
dependent polarization. 
 
The suitable fluorescein and ruthenium MLC membrane probes have to 
accomplish  
(a) a temperature-dependent polarization in glycerol,  
(b) a sensitivity to the phase transition of DPPC at 41 °C when 
embedded in DPPC liposomes, and 
(c) a cholesterol sensitivity when embedded in DPPC liposomes with 
variable cholesterol content. 
4.4.1. Temperature-dependent steady-state polar izat ion  
Membrane probes in glycerol 
Due to its high viscosity, glycerol was used as the solvent instead of aqueous 
solutions to dissolve the membrane probes. An increased viscosity reduces 
the rotational freedom of the membrane probe enabling polarization 
measurements. The fluorescence  polarization was quantified as a function of 
the temperature or rather the viscosity of the solvent. Both the fluorescein 
(figure 4-8) and the ruthenium MLC membrane probes (figure 4-9) indicate a 
change in polarization by varying the temperature. The membrane probe 
Ru-2-PE2 could not be specified directly due to the low solubility in a 
glycerol/water mixture. 
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Fig. 4-8. Temperature- dependent polarization of the fluorescein 
membrane probes in glycerol. 
 
 
Fig. 4-9. Temperature- dependent polarization of the ruthenium MLC 
membrane probes in glycerol. 
 It is found that the fluorescein membrane probes Fl-PE, Fl-C18 and 
Fl-C16 have polarization values higher than 0.4. This is attributed to the low 
lifetime (4 ns) of the fluorescein derivatives, since the polarization is inversely 
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proportional to the lifetime of the respective dyes (see chapter 2). As 
expected, the polarization values of the ruthenium MLC membrane probes 
were found to be about 0.1 owing to their lifetime which is in the range of 
hundred nanoseconds.   
 All membrane probes have two fatty acyl residues (non-polar tail). The 
fluorescein as well as the ruthenium MLC membrane probes tend to have an 
increased polarization in contrast to the membrane probes with only one lipid 
anchor. This effect can be directed to the reduced rotational freedom caused 
by the two anchors attached to the  fluorophore. In comparison to the 
fluorescein membrane probes in glycerol, the ruthenium MLC probes show an 
enhanced change in polarization with temperature (see table 4-1). This effect 
may be a first hint for preferring the ruthenium MLC membrane probes.   
Table 4-1.  Temperature-dependent polarization (P) of the fluorescein and 
ruthenium MLC membrane probes in glycerol. 
membrane probe P (12 °C) P (35 °C) D P 
Fl- PE  0.431 0.400 0.031 
Fl- C18 0.423 0.393 0.030 
Fl- C16 0.389 0.358 0.031 
Ru-2-(C18H37)2 0.137 0.081 0.056 
Ru-2-(C16H33)2 0.128 0.074 0.054 
Ru-1-PE 0.121 0.057 0.064 
Ru-1-C16H33 0.090 0.030 0.060 
Ru-1-C18H37 0.080 0.024 0.056 
 
 
Fluorescein and ruthenium MLC membrane probes in DPPC 
The polarization behavior of the membrane probes at the phase transition 
temperature of DPPC liposomes (i.e. 41 °C) was investigated. The membrane 
probes Fl-PE and Ru-2-PE2 were first studied in terms of their polarization 
sensitivity to phase transition. The probes were incorporated in DPPC 
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liposomes as described in chapter 4.2.1. The results are depicted in 
figure 4-10. Fl-PE has an increased polarization, but there was no change in 
polarization at the phase transition temperature of DPPC. The same results 
were obtained for the dyes Fl-C16 and Fl-C18. Obviously, the low lifetimes of 
the fluorescein membrane probes are the reason for no lateral diffusion in the 
DPPC liposomes. In contrast, Ru-2-PE2 displays the typical phase tranisition 
at 41 °C. Its significant change in polarization of 0.13 at the phase transition 
temperature of DPPC makes the group of the amphiphilic ruthenium metal-
ligand complexes to a promising luminophore for studying membrane dynamics. 
Therefore, the ruthenium MLC membrane probes were used for further 
investigations. 
 
Fig. 4-10. Temperature- dependent polarization of the ruthenium MLC 
membrane probes in glycerol. Faced with Fl-PE, Ru-2-PE2 displays a 
slope at the phase transition temperature of 41 oC of  DPPC. 
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Varying chain length and ligand 
The effect of the chain length of membrane probes with the same anchor type 
on polarization was investigated for the pair Ru-2-(C16H33)2 and 
Ru-2-(C18H37)2. It was found that the two membrane probes display similar 
polarized emission at 35 °C.  Additionally, the sensitivity in polarization to 
phase transition (DP) was identical (table 4-2). A similar result was obtained 
for the pair Ru-1-C16H33 and Ru-1-C18H37.  
Table 4-2.  Temperature-dependent polarization of ruthenium MLC membrane 
probes incorporated in DPPC liposomes. 
membrane probe P (35 °C) P (45 °C) D P 
Ru-2-( C16H33)2 0.126 0.029 0.097 
Ru-2-(C18 H37)2 0.128 0.036 0.092 
Ru-phen2-(C16 H33)2 0.127 0.035 0.092 
Ru-1- C16H33 0.112 0.053 0.059 
Ru-1- C18 H37 0.114 0.053 0.061 
 
At last, the effect of the ligands on the properties of the membrane 
probes in liposomes were quantified with the ligands bipyridyl (Ru-2-(C16)2) and 
phenanthroline (Ru-phen2-(C16)2). As one can see in table 4-2, no significant 
difference in temperature-dependent polarization was observed. 
The results demonstrate that the membrane probes of the type 
Ru-1-R, Ru-1-C16H33 and Ru-1-C18H37 exhibit a reduced polarization effect in 
terms of phase transition. As a result, these two probes were excluded from 
further measurements. For the membrane probes with two anchors, 
Ru-2-(C16)2 acts as representative for the probes Ru-2-(C18H37)2 and 
Ru-phen2-(C16)2, because the same polarization behavior was found at phase 
transition in DPPC liposomes. In the following chapter, the investigation were 
restricted to the three most promising membrane probes Ru-2-(C16)2, 
Ru-1-PE and Ru-2-PE2. The dye derivatives were evaluated for the use as 
Chapter 4:  Membrane Probes 
 
page 47 
membrane probes in terms of emission intensity, temperature-dependent 
polarization and cholesterol-dependent polarization.  
4.4.2. Characterization of the membrane probes Ru-2-(C16)2, Ru-1-PE and 
   Ru-2 -PE2 
Spectral characterization 
The absorption and emission spectra of probe Ru-2-(C16)2 in DPPC liposomes 
with and without cholesterol are shown in figure 4-11.  
 
Fig. 4-11. Absorption and emission spectra of   Ru-2-(C16)2  in DPPC  
(- - - - ) and DPPC / cholesterol (1:1) (_____) liposomes at 20 oC. 
 
The maximum of the low energy absorption band at about 450 nm is the 
characteristic metal-to-ligand charge transfer transition of an MLC of the 
Ru(bipy) type.  This band is hardly affected by the environment.  In comparison 
to the emission maxima of the respective carboxy compounds (without lipid 
side chain), which are at 610 nm, the emission maxima of the membrane 
probes are shifted to longer wavelengths (647 - 674 nm; see table 4-3).  This 
effect is observed only in case of incorporation into liposomes, while in 
chloroform solution the emission maxima are in the range of 610 nm.  The 
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bathochromic shift is assumed to be due to solvent effects since similar 
spectra are observed in methanol solution and related effects have been found 
elsewhere [20]. Characteristic spectroscopic data of the membrane probes 
Ru-1-PE, Ru-2-PE2, and Ru-2-(C16)2  are summarized in table 4-3. 
Table 4-3.  Absorption and emission maxima (in nm) of membrane probes  
 Ru-1-PE, Ru-2-PE2 and Ru-2-(C16)2 in liposomes at 22 °C. 
probe lmax (abs) lmax (em) in  
DPPC 
lmax (em) in 
DPPC/cholesterol (1:1) 
 Ru-1-PE  456 647 655 
Ru-2-PE2 456 666 674 
Ru-2-(C16)2 456 659 666 
  
 The existence of phase transitions within membranes is a characteristic 
feature of liposomes.  The membrane probes were embedded in DPPC as 
described.  The emission intensity of these liposomes depends on 
temperature.  An increase in temperature showed a small shift to lower 
emission intensities and a sharp decrease at the phase transition 
temperature (Tm) of DPPC at 41 °C, as can be seen in figure 4-12.  This 
behavior is typical [21] for Ru-MLC complexes due to the enhancement of 
nonradiative decay pathways.  At temperatures below the phase transition, 
the probes can be assumed to be located closer to the interior of the lipid 
bilayer and therefore to be protected from fluorescence quenching by water.  
Above the transition temperature, the probes are pushed out of the bilayer 
and localized at the lipid-water interface.  This effect is more obvious for 
Ru-2-(C16)2  which can be assumed to be closer to the membrane bilayer 
because of the presence of two alkyl chains.   
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Fig. 4-12. Temperature- dependent fluorescence of the membrane 
probes  Ru-1-PE , Ru-2-PE2 and Ru-2-(C16)2   incorporated into DPPC 
liposomes. 
 
Lifetime Measurements 
Time-resolved fluorescence measurements of the probe Ru-2-(C16)2 at several 
temperatures are presented in figure 4-13.  The data were analyzed assuming 
a single exponential decay. The data for the probes Ru-1-PE, Ru-2-PE2 and 
Ru-2-(C16)2  incorporated in DPPC as a function of both the temperature and 
the phospholipid/cholesterol ratio are compiled in table 4-4.  
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Fig. 4-13.  Frequency- domain intensity decays of  Ru-2-(C16)2  in 
DPPC liposomes at various  temperatures. 
 
Table 4-4. Fluorescence lifetimes t (in ns) of probes  Ru-1-PE , Ru-2-PE2, and  
 Ru-2-(C16)2  in DPPC liposomes and in DPPC/cholesterol (1:1)  
 liposomes (data in brackets). 
 
probe t (5 °C) t (20 °C) t (35 °C) t (45 °C) t (55 °C) 
 Ru-1-PE  485 
(448) 
443 
(401) 
415 
(397) 
382 
(374) 
379 
(347) 
Ru-2-PE2 612 
(550) 
522 
(482) 
463 
(408) 
408 
(392) 
357 
(351) 
Ru-2-(C16)2 624 
(551) 
597 
(494) 
509 
(423) 
434 
(416) 
385 
(389) 
  
 The mean decay times of Ru-2-PE2 and Ru-2-(C16)2  drop from 
approximately 600 ns at 5 °C to ~ 400 ns at 55 °C. The lifetime of Ru-1-PE is 
shorter and less affected by the micro-environment.  This can be reasoned by 
the possibility of free rotation of the probe on the membrane surface. Due to 
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their long decay times, the MLC membrane probes can be used to measure 
rotational motions in membranes up to 2 µs, i.e. three times the mean decay 
time [22]. On increasing the fraction of cholesterol in the liposomes, the 
decay times decrease steadily.  In the liquid-crystalline phase, the lifetimes 
are quite similar to those in pure DPPC liposomes. 
Temperature-dependent steady-state polarization  
In order to be useful for lipid hydrodynamic studies, the probes need to display 
polarized emission. Because of the poor solubility of the membrane probes in 
water:glycerol, the maximal polarization of the carboxy MLCs Ru-(bpy)2(mcbpy) 
and Ru-(bpy)2(dcbpy) were measured and found to be 0.17 and 0.23, 
respectively (21).  The polarization spectrum of the synthesized MLC 
membrane probes are similar to the polarization spectra of (a) the free 
carboxy acids of the MLCs (10) and (b), the MLC carboxy compound covalently 
linked to the amino groups of proteins [23].   
 
Fig. 4-14. Temperature- dependent fluorescence polarization of  
Ru-1-PE , Ru-2-PE2 and Ru-2-(C16)2  incorporated into DPPC in a 
ratio of 1:100. 
  
30 35 40 45 50 55
0,1
0,2
0,3
Ru-2-(C
16
)
2
  
Ru-1-PE
Ru-2-PE
2
  
p
o
la
ri
za
ti
o
n
temperature / °C
Chapter 4:  Membrane Probes 
 
page 52 
The steady-state fluorescence polarization data were acquired between 30 
and 55 °C, i.e. under conditions where DPPC is either in the gel state or the 
liquid-crystalline state. The steady-state fluorescence polarization data of the 
membrane probes are presented in figure 4-14. The polarization decreases 
progressively with increasing temperature as expected for a probe undergoing 
thermal motion.  The steady-state fluorescence polarization of the membrane 
probes is significantly lower in the liquid-crystalline state than in the gel phase 
of DPPC, suggesting that greater static and dynamic molecular disorder is 
present in the liquid-crystalline phase of the bilayer (figure 4-14). A sharp 
phase transition occurs about 41 °C for all membrane probes, which is in 
accordance with findings obtained with DPH-labeled membranes [24]. Ru-2-
(C16)2 shows the highest sensitivity to phase transition, probably because of 
the presence of two lipid chains which may reduce free rotation in the 
membrane.  A second reason for this finding may result from a closer 
distance between the chromophore of Ru-2-(C16)2 and its lipid anchor located 
in the liposome membrane (in comparison to Ru-1-PE and Ru-2-PE2). 
Cholesterol-dependent steady-state polarization  
Cholesterol is an integral part of melanoma cell membranes and known for 
non-covalent association with lipids within the cell [25]. Such interactions can 
affect the orientational order of lipid hydrophobic chains in membranes [26-
32] which, in turn, can change the solid-fluid transition temperature of the 
resulting bilayers [33]. The probe Ru-2-(C16)2, solubilized in various vesicular 
assemblies, was used to measure the effect of cholesterol on the polarized 
emission of Ru-2-(C16)2. In phospholipid liposomes, cholesterol differently 
modifies the gel phase and the liquid-crystalline phase. The disorder of the gel 
phase increases on addition of  cholesterol, while the liquid crystalline phase 
becomes more ordered on addition of cholesterol [34-35].   
 As expected, the incorporation of cholesterol into DPPC bilayers reduces 
the disorder in the liquid-crystalline state of our membrane probes, as can be 
deduced from the observed larger steady-state polarization (figure 4-15).  In 
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contrast to the behavior in the liquid crystalline state, the polarization was 
smaller in liposomes with a higher fraction of cholesterol.  It can be  assumed 
that this is due to the enhanced rotational freedom of the dye in the gel 
phase.   
 
Fig. 4-15. Temperature dependence of the steady- state 
fluorescence polarization of  Ru-2-(C16)2  in DPPC/cholesterol 
liposomes at various sterol concentration. 
 
 To compare the membrane probes in terms of sensitivity to cholesterol, 
the differences in the polarization in the liquid crystalline form and in the gel 
phase, respectively, were plotted against the fraction of cholesterol in the 
DPPC liposomes.  The results are shown in figure 4-16.  The probe  Ru-1-PE  
displays low sensitivity to cholesterol.  In contrast, Ru-2-PE2 and Ru-2-(C16)2  
display sensitivity to cholesterol in the range from 0 to 30% cholesterol in the 
DPPC liposomes. Ru-2-(C16)2 is more sensitive. It is important to note that 
the results obtained with the ruthenium MLCs are quite similar to those 
obtained with DPH (which was often used for cholesterol-dependent 
measurements in liposomes). 
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Fig. 4-16. Comparison of membrane probes  Ru-1-PE , Ru-2-PE2 and 
Ru-2-(C16)2  in terms of the  polarization at 30 
oC and 50 oC  in 
liposomes of DPPC containing different fractions of cholesterol. 
 
4.4.3. Real  sample: Ru-1 -PE as membrane probe in erythrocytes1 
The membrane probe Ru-1-PE was incorporated into a real sample, namely 
erythrocytes. The determination of the cholesterol content in erythrocytes in 
arteriosclerosis research is of large clinical interest. A way to quantify 
cholesterol is to specify the viscosity of the erythrocytes. The first step to 
enable such a measurement is to identify a membrane probe that can be 
incorporated into a living cell. For this purpose Ru-1-PE was incubated in 
erythrocytes and the temperature-dependent polarization was measured. The 
polarization of the probe in erythrocytes was six times higher in comparison 
to the probe in PBS. This effect verifies the incorporation of Ru-1-PE in the 
erythrocytes resulting in a higher polarization value due to reduced rotational 
                                                 
1 Measurement was performed in cooperation with the Department of Clinical 
Chemistry (Dr. G. Rothe, Prof. G. Schmitz), University of Regensburg 
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freedom of the membrane probe.  The clinical evaluation of the system will be 
performed by the Department of Clinical Chemistry, University of Regensburg. 
 
Fig. 4-16. Temperature- dependent polarization of Ru-1-PE in PBS 
with and without erythrocytes. 
4.5. Conclusion 
This work demonstrates that the new amphiphilic MLC probes are sensitive to 
membrane order and dynamics. However, their suitability strongly depends on: 
(a) the degree of the rotational freedom of the dye, (b) the lipophilicity of the 
probes and (c) the effect of the length of the spacer between the hydrophobic 
and the hydrophilic part of the probe.  The results also demonstrate that the 
Ru-MLC probe with only one lipid anchor (Ru-1-R) is less sensitive to 
polarization and emission intensity than the two-anchor probes Ru-2-PE2 and 
Ru-2-(C16)2, both in terms of phase transitions and the fraction of cholesterol 
in the membranes. 
 Another aspect concerns the location of the Ru-MLC in the bilayer.  The 
type of lipid covalently linked to the metal-ligand complex governs for the 
location of the dye in the bilayer.  In fact, Ru-2-(C16)2  shows higher sensitivity 
(in terms of polarization) to changes in membrane composition than the 
amphiphilic dye Ru-2-PE2.  Because the Ru-MLC Ru-2-PE2 is linked to two 
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phospholipids, one can assume that the two headgroups (which are polar) 
tend to partition to the hydrophobic surface of the bilayer.  Membrane probe 
Ru-2-(C16)2, which is linked to two hydrophobic alkyl chains, is likely to reside 
deeper in the hydrophobic interior of the bilayer.   
 The effect of the length of the spacer between the lipid chain and the 
MLC needs to be considered as well. Ru-2-PE2 has a short (C2) spacer 
between the chromophore and the phospholipid. Ru-2-(C16)2, in contrast, has 
a direct link to the alkyl chain and the MLC therefore can reside closer to the 
membrane surface.  This seems to make Ru-2-(C16)2  the probe of choice for 
biophysical membrane studies such as the effect of cholesterol on the rigidity 
of membranes. 
 In summary, we consider the MLC type probes to have particular 
advantages. These include (a) broad absorption bands (ranging from 
approximately 430 to 490 nm) which makes the probes excitable by blue LEDs 
and the argon ion laser; (b) emission maxima (at 640 nm) that are well 
separated from the excitation wavelengths and thus are hardly interfered by 
stray light; and (c) lifetimes in the order of 400 to 600 ns, thus enabling 
studies on membrane dynamics in the µs time regime (3 t). 
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5. HSA Immunosystems 
 
 
In this chapter a luminescence polarization immunoassay based on a 
ruthenium metal-ligand complex Ru-(bipy)2-(mcbpy) (Ru-1) is described. The 
lifetime of Ru-1 allows the measurement of rotational motions of proteins. 
For this purpose, the NHS ester of Ru-1 was synthesized and conjugated to 
human serum albumin (HSA). The pract ical i ty of th is complex for 
immunoassays was determined by titration of the labeled HSA with non -
labeled anti-HSA. In addition, a competitive assay for HSA was developed, 
too. Both assays are based on the polar izat ion method. 
 
Furthermore, a  novel immunosystem is described that exploits the 
effect of luminescence energy transfer from a luminescently labeled antigen 
to a fluorescently labeled antibody.  A luminescent ruthenium-ligand complex 
(Ru-1) was used as the donor label, and a blue squaraine label as the 
fluorescent acceptor label.  Specifically, HSA was labeled with Ru-1, and anti-
HSA was labeled with RB-631. On formation of the antigen-antibody complex, 
energy transfer occurs. The radiationless energy transfer affects both the 
decay time of the Ru-1 and the intensities of the emissions of the Ru-1 and 
RB-631, respectively. The long decay time of Ru-1 (500 ns) allows frequency-
domain measurements in the low kHz range and therefore can be based on 
the use of low-cost opto-electronics. The major difference to existing HSA 
immunosystems is the use of a long delayed ruthenium metal-ligand complex 
as donor and a squarine dye with a high quantum yield as the acceptor. 
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5.1. HSA polarization immunosystem 
5.1.1. Introduction  
State of the art  
Fluorescence based assays are widely used in analytical and clinical chemistry 
[1-3]. Such systems can be based on a variety of mechanism affecting the 
observed spectral properties like quenching, energy transfer or emission 
polarization. Immunoassays based on polarization or anisotropy are among the 
most widely used methods [4-7]. Fluorescence polarization immunoassays are 
based on polarization measurements of antigens labeled with fluorescent 
markers [8-10]. 
Theory 
Fluorescence polarization methods are applied to study the interactions of 
proteins with other macromolecules. The background for such measurements 
are optical effects like the polarization or rather the anisotropy. The 
polarization can be easily converted to the anisotropy (see chapter 2) [11]. 
The anisotropy (r) is related directly to the rotational correlation time (q) and 
to the molecular weight (MW) of a biosystem (eq. 5-1). The anisotropy of a 
labeled macromolecule is given by 
      
qt+
=
1
0rr      (5-1) 
where r0 is the value observed in the absence of rotational diffusion. The 
molecular volume of the protein is related to the molecular weight and the 
rotational correlation time q 
     )( h
RT
MW
kT
V
+== n
hh
q     (5-2) 
with R as the ideal gas constant, n  is the specific volume of the protein, and 
h is the hydration. In aqueous solution at 20 °C (h = 1 cP) one can expect a 
protein such as human serum albumin (HSA; molecular weight 
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~65,000 Dalton, with n  + h = 1.9) to display a rotational correlation time 
close to 50 ns [12]. 
 In the case of binding or release of labeled HSA from the 
antibody/anti-HSA complex, the rotational correlation time changes, and 
consequently the polarization (figure 5-1). Information on the rotational 
motion is available over a time scale not exceeding three times the lifetime of 
the fluorophore. For longer rotational motions the signal is too low to affect 
the steady-state polarization. Since the lifetimes of typical fluorophores range 
from 1 to 10 ns, it is difficult to measure rotational correlation times higher 
than 30 ns. Therefore, polarization studies are usually limited to substances 
with molecular weights of less than 50 000 Daltons. The limitations imposed 
by the short fluorescence lifetime have been circumvented by the use of 
phosphorescence polarization [13, 14]. Such measurements are based almost 
exclusively on the triplet probe eosin, which displays a millisecond 
phosphorescence decay time in the absence of oxygen. However, there are 
few useful triplet probes. The use of phosphorescence is also inconvenient due 
to the need of total exclusion of molecular oxygen, and the low initial 
phosphorescence polarizations, typically 0.1 or lower [15].  
 On the opposite, ruthenium-ligand complexes display emissions from 
charge-transfer states with decay times ranging from 100 ns to 4 µs in 
solutions along with reasonable quantum yields [16]. 
5.1.2. Methods 
Labeling Procedure 
Protein labeling was carried out in a 50 mM bicarbonate buffer of pH 9.0. A 
stock solution of 1 mg of the NHS ester Ru-1 (see figure 5-9) in 100 µL of 
anhydrous dimethylformamide was prepared and 5 mg of protein were 
dissolved in 1 mL of the bicarbonate buffer. Defined volumes (50 to 40 µL) of 
the stock solution of the respective label were added to the protein solution 
and the mixture was gently stirred for 5 h (HSA) or for 2 h (anti-HSA). 
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Unconjugated label was separated form the labeled proteins using gel 
permeation chromatography in a 0.5 x 20 cm column filled with Sephadex 
G25. A 22 mM phosphate buffer of pH 7.2 was used as the eluent. The 
fast-running fraction contained the dye-protein conjugate, while the fraction 
with an increased retention time contained the separated free dye. 
 
Determination of the dye- to protein ratios 
The labeling degree of (the “dye-to-protein ratio“, D/P) is defined as the 
molarity of label over the molarity of the protein. The degree of labeling of the 
conjugates was determined by absorptiometry of the conjugates and 
assuming that the molar absorbance (e) of the bound dye is the same as 
that of the free dye. The dye-to-protein ratio (D/P) statistically gives the 
number of labels covalently bound to a single protein. 
5.1.3. Polar izat ion immunoassay 
To evaluate the feasibility of using Ru-1 in a polarization immunoassay, 
Ru-1/HSA was used as an antigen. The changes in emission intensity, lifetime 
and polarization of Ru-1 labeled HSA were examined in the presence of 
increasing amounts of anti-HSA (figure 5-1). 
a n t i - H S A
R u-1/H S A
D
D
D
D
 
 Fig. 5-1. Scheme for the polarization assay on the system HSA/anti-HSA. 
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Spectral characterization 
The absorption and emission spectra of Ru-1 unlabeled and Ru-1 labeled to 
HSA are shown in figure 5-2.  
 
Fig. 5-2. Emission spectra of free label and Ru-1- labeled HSA. 
 
The spectra are normalized to unity. The absorption spectra of free label and 
HSA labeled Ru-1 are identical. The emission maximum of Ru-1 at 610 nm is 
slightly shifted to longer wavelengths if covalently bound to HSA.   
Emission intensity 
Ru-1/HSA was titrated with non-labeled anti-HAS, and the results are plotted 
in figure 5-3. There was no change in emission intensity with increasing 
amount of anti-HSA observed. This experiment evaluated the assumption that 
the decrease of the donor fluorescence is not due to quenching of the 
proteins but due to energy transfer. 
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Fig. 5-3. Emission spectra of Ru-1- conjugated to HSA with 
increasing concentration of anti-HSA. 
 
Lifetime measurements 
The results of the decay time analysis of Ru-1/HSA are summarized in 
table-5-1. The decays fit best a second exponential decay is taken into 
account. The mean decay time was approximately the same for all anti-HSA 
concentration, with an average decay time of 485 ns. 
 
Table 5-1.  Intensity decay analysis of Ru-1/HSA at various concentrations of  
 anti-HSA. 
HSA
HSAanti
/1-Ru
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2
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Steady-state fluorescence polarization 
The maximum polarization of the excited state lifetime of Ru-1 in vitrified 
solution (glycerol, -60 °C), where rotational diffusion does not occur, was 
0.17. This was already examined by Lakowicz et al.[17]. The Ru-1 complex 
shows polarized emission. 
To evaluate the usefulness of Ru-1 in an immunoassay, we investigated 
the steady-state polarization of Ru-1 conjugated to HSA in the presence of 
increasing quantities of anti-HSA. The results are shown in figure 5-4. The 
polarization increased by about four times at a molar ratio of Ru-1/HSA to 
anti-HSA of 1:4. Hence, the polarization of Ru-1/HSA is sensitive to the rate 
of rotational diffusion associated to the antigen/antibody complex.  
 
 
Fig. 5-4. Steady- state polarization of Ru-1 conjugated to HSA at 
various concentrations of anti-HSA. 
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5.1.4. Compet it ive polar izat ion immunoassay 
D
D
H S A
a n t i - H S A
 
 Fig. 5-5. Model for the competitive polarization based immunoassay on the 
system HSA / anti-HSA. 
 
In a competitive immunoassay labeled and unlabeled antigens are allowed to 
simultaneously compete for the binding sites of the antibody (figure 5-5). The 
simultaneous exposure of labeled and unlabeled HSA to anti-HSA resulted in 
changes in polarization. Three titrations with increasing anti-HSA 
concentrations (1, 2 and 4 nmol/L) were carried out. The concentration of 
Ru-1/HSA was hold constant at 1 nmol/L for all titrations. The amount of anti-
HSA was unchanged for each titrations at (1, 2 and 4 nmol/L, respectively). 
We found an exponential decay of the polarization with increasing fraction of 
unlabeled HSA for all titrations (figure 5-6). At high concentration of unlabeled 
HSA, the polarization could not be reversed to the value for unbound Ru-
1/HSA with a polarization value of 0.33, which should be observed on total 
replacement of Ru-1/HSA with unlabeled HSA. This effect can be attributed to 
nonspecific binding of Ru-1/HSA to other proteins present in solution. Another 
reason for this behavior may result from a stronger binding affinity for Ru-
1/HSA than for free HSA. 
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Fig. 5-6. Steady- state polarization of Ru-1 conjugated to HSA at 
rising concentrations of unlabeled HSA competing for anti-HSA. 
 
5.1.5. Conclusion  
The label Ru-1 turned out to be a very useful probe for performing 
immunoassays for high-molecular weight antigens. The favorably properties of 
Ru-1 allow the use of simple instrumentation: The advantage of Ru-1 is due to 
a Stokes’ shift of more than 150 nm, which makes the separation of 
excitation and emission light easy, and an excitation maximum of 456 nm, 
which allows excitation with an argon ion laser or a blue LED. The emission 
maximum is at 641 nm when bound to HSA. At this wavelength the 
interference from the autofluorescence of biological samples is reduced.  
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5.2. HSA fluorescence energy transfer immunosystem 
5.2.1. Introduction 
State of the art  
The quantitative determination of human serum albumin (HSA) in biological 
liquids has gained importance in diagnosis and preventive medicine [18]. 
Except for blood serum, albumin concentrations in body fluids such as urine 
are usually low and therefore require sensitive methods for their precise 
determination. 
 Numerous protocols for determination of HSA are reported in the past 
decade [19-22]. Among those, immunoassays based on fluorescence 
detection have been preferred in practice. These include immunoassays based 
on fluorescence polarization [23] and fluorescence resonance energy transfer 
(FRET) [24]. 
 This detection scheme exploits the fact that electronic (photonic) energy 
of a first fluorophore can be transferred to a second fluorophore, if the 
second is in sufficient and spatial proximity. As a result, the fluorescence 
intensity (and decay time) of the first fluorophore decreases, while the 
intensity of the second increases [11]. 
 FRET occurs over distances between typically 1-7 nm, and it is a 
fortunate incidence that this is the average distance of an antigen (Ag) and an 
antibody (Ab) once they are bound to each other. Hence, the fact that FRET 
does occur is indication that a (labeled) antibody has recognized its (labeled) 
antigen.  The efficiency of energy transfer between Ag and Ab depends on the 
sixth power of the distance between the donor and acceptor.  
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Fig. 5-7. Scheme for the luminescence energy transfer in the system HSA (donor-
labeled) and anti-HSA (acceptor labeled). 
 
 This energy transfer system is illustrated in figure 5-7. We used HSA as 
an antigen covalently labeled with the donor Ru(bpy)2-(mcbpy) (Ru-1). The 
antibody (anti-human serum albumin, anti-HSA) was labeled with the acceptor 
RB-631. We found that the emission intensity of the acceptor increased, 
while the lifetime of the ruthenium labeled antigen decreased upon binding to 
acceptor-labeled antibody.  
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5.2.2. Labeling procedures 
General protein- labeling procedures and determination of dye- to protein ratios  
The same labeling procedure was used as described in chapter 5.1.3. 
 
Fig. 5-8. Separation of the unconjugated label from the protein 
labeled using gel permeation chromatography (left: RB-631/anti-HSA; 
right: Ru-1/HSA). 
 
Procedure for studying energy transfer efficiency 
100 µL of the donor solution (Ru-1/HSA) in phosphate-buffered saline (PBS; 
22 mM, pH 7.2) was mixed with RB-631/anti-HSA acceptor solution, typically 
5 to 400 µL. The mixtures were diluted with PBS to a final volume of 600 µL 
and incubated for 15 min at room temperature. Then, the fluorescence 
intensity or decay time was measured. 
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5.2.3. Results 
Choice of labels 
The choice of dyes is a key issue in designing resonance energy transfer 
systems. The decay times of commonly used donor fluorophores typically are 
in the nanosecond region and this makes measurement of decay times more 
tedious. One solution is to apply long-decaying labels such as europium 
chelates [25]. These, however, require short wavelength excitation [26]. 
Other labels that have been proposed may be oxidized by oxygen, have poor 
quantum yields, or be susceptible to quenching by proteins [27]. Ru-MLCs can 
overcome some of these limitations since they have  lifetimes in the order of 
several hundred nanoseconds, can be excited with a 488 nm argon ion laser 
and exhibit a strongly red-shifted emission maximum at 610 nm. Therefore, 
we decided to use the ruthenium label Ru-1 as the donor dye. Furthermore, 
its synthesis is fairly easy. 
 
 The acceptor dye was chosen such that is an absorption maximum close 
to the emission maximum of the ruthenium label. Both dyes have the 
additional advantage that their emission is in the optical window of blood and 
biological tissue, i.e. between 630 and 670 nm, thus minimizing re-absorption 
of light. 
Spectral characterization of labels 
Ru-1 exhibits a large Stokes’ shift (approx. 150 nm) with no overlap of the 
excitation and emission spectra. Therefore, excitation light can be easily 
separated from emitted light. Decay times in the order of 500 ns allow decay 
time measurements to be made, which are independent of the concentration 
of the donor label. 
  
 RB-631 (the acceptor) also has a rather high molar absorbance of 
95,000 L/(mol· cm) and a quantum yield of 0.32 when bound to proteins. The 
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chemical structures of the activated Ru-1 and RB-631 are shown in 
figure 5-9, the photophysical data are summarized in table 5-2. 
 
 
 
Fig. 5-9. Chemical structeres of the N-hydroxy succinimide esters of 
the donor dye Ru-1 and the acceptor dye RB-631. 
 
 
Spectral characterization of the protein conjugates 
The absorption and emission spectra of the Ru-1/HSA conjugate and the 
RB-631-labeled antibody (RB-631/anti-HSA) are depicted in figure 5-10. The 
emission maximum of Ru-1 at 610 nm is slightly shifted to longer wavelengths 
when covalently bound to HSA. The absorption and emission maxima of 
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RB-631/anti-HSA can be found at 636 nm and at 655 nm, respectively. Like 
Ru-1, RB-631 shows a bathochromic shift in its absorption and emission 
maximum in the protein-bound form. There is sufficient spectral overlap 
between the emission of the donor and the long wavelength absorption of the 
acceptor.  
 
Fig. 5-10. Absorption and emission spectra of   Ru-1 (- - - - ) and  RB-631 
(_____). For lmax values, absorbances and quantum yields see table 5-2. 
 
Quantum Yields 
The following equation [29] was used for the determination of the quantum 
yield (QY): 
 
  ( )ff FFQYQY ReRe /= .       (5-4) 
where 
  ( ) ll dIF ò=          (5-5) 
 
The QY of the donor was estimated by comparing the dye [Ru(bpy)3]2+ whose 
QY is reported to be 0.042 [30]. The QY of RB-631 was determined relative 
to that of the dye Cy5, whose QY is reported to be 0.25 [31].  
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 The luminescence of ruthenium metal ligand complexes, especially the 
phenanthroline complexes, is known to be quenched by oxygen. Therefore, we 
have investigated the effect of oxygen on the QY of both the free and the 
protein-bound form of Ru-1 by measuring luminescence intensity in air-
equilibrated solution and in argon-equilibrated solution, respectively. Compared 
to deoxygenated solutions, the relative QYs for Ru-1 and Ru-1/HSA in air-
equilibrated buffer solutions were 0.79 and 0.91, respectively. Hence, the 
free ruthenium label is more sensitive to oxygen than the protein conjugate.  
However, the cross-sensitivity to oxygen is not large enough to cause serious 
interference. 
 
Table 5-2. Spectral properties and quantum yields of dyes and dye-protein  
  conjugates in PBS of pH 7.2. 
Dye Abs.max. 
[nm] 
Em. max. 
[nm] 
e  
[L/(mol· cm)] 
Q.Y. D/P 
[mol/mol] 
Ru-1 456 610 18,000 0,051 ___ 
Ru-1/HSA 456 639 a 0,055 4,0 
[Ru(bipy)3]2+ 456 610 15000 0,042 ___ 
RB-631 631 645 95,000 0,04 ___ 
RB-631/anti-HSA 636 655 a 0,32 4,9                                               
Cy5 647 664 250,000 0,25 ___ 
a Not determined 
 
Energy transfer studies based on measurement of luminescence intensity  
The results of a representative energy transfer experiment are shown in 
figure 5-11.   Ru-1 labeled HSA (DPR  = 4.0; [HSA] = 3.2 µM) was mixed with 
RB-631/anti-HSA  (DPR = 4.8) in molar ratios of 1:4, 1:2, 1:1, 1:0.75, 
1:0.5, 1:0.25, 1:0 and 0:1. As expected, the luminescence intensity of 
Ru-1/HSA decreases with increasing quantities of RB-631/anti-HSA, while the 
fluorescence of the RB-631/anti-HSA conjugate increases because of 
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resonance energy transfer. The luminescence of plain RB-631/anti-HSA in a 
concentration of 3.2 µM is only 25% of the emission intensity of the pair 
Ru-1/HSA / RB-631/anti-HSA at the same concentration. The excitation 
wavelength was 450 nm in both cases. The detection limits of Ru-1/HSA and 
of RB-631/anti-HSA, respectively, are at about 0.5 µM and 0.1 µM using a 
150 Watt xenon lamp. 
 
 The donor/HSA conjugate was also titrated with unlabeled anti-HSA. The 
emission intensity of Ru-1/HSA does not change with increasing 
concentration of anti-HSA. This demonstrates that the decrease in the donor 
fluorescence shown in figure   5-11 is not due to fluorescence quenching by 
the protein but due to energy transfer.  
 
Fig. 5-11. Luminescence energy transfer study in the system 
HSA/anti-HSA. Ru-1/HSA (D/P=  4.0) of constant concentration 
(3.2 µM) was titrated with RB-631/anti-HSA (D/P=  4.8) and emission 
spectra were recorded at lexc= 460 nm. 
 
 All spectra shown in the following were normalized to unity for 
comparison purposes. Figure 5-12 shows the effect of increasing fractions of 
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RB-631/anti-HSA on the emission intensity of Ru-1/HSA.  The signal drops 
until the molar ratio between RB-631/anti-HSA and Ru-1/HSA is 4:1, where 
the signal has decreased by 34%. If the titration is performed with unlabeled 
anti-HSA, no decrease in intensity is observed since energy transfer cannot 
occur. 
 
Fig. 5-12. Changes in emission intensity of Ru-1/HSA in presence of 
increasing fractions of (a) RB-631/anti-HSA (__¾__¾__)  and (b) non-
labeled anti-HSA (- -- -- - ) concentration, respectively. 
 
Energy transfer studies based on measurement of luminescence decay time.   
To further characterize the FRET in the antigen-antibody system, we 
investigated the decay times of Ru-1/HSA. In the absence of acceptor, the 
decay time was mono-exponential with a dominant component of 488 ns (see 
table 5-3). An investigation of the effect of oxygen on the decay time of the 
free and protein bound form was carried out as described before for the QYs. 
The decay times for Ru-1 and Ru-1/HSA in air-equilibrated and argon-
equilibrated buffer solutions were found  at 375 ns (517 ns) and 488 ns 
(512 ns), respectively. The decay time measurements are in accordance with 
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the measurements of the QY. Therefore, measurements were carried out 
without further oxygen exclusion. 
  
Table 5-3. Intensity decay analysis of Ru1/HSA at various concentrations of  
 RB-631/anti-HSA and anti-HSA, respectively. 
RB-631/anti-HAS 
HSA
HSAanti
/1-Ru
-
 ti (ns) fi 2Rc  
0,488 0,98 4,1 0 
0,001 0,02  
    0,434 0,82 4,2 0,25 
0,035 0,18  
    0,412 0,72 3,9 0,5 
0,033 0,28  
    0,396 0,61 4,1 0,75 
0,030 0,39  
    0,379 0,55 5,3 1 
0,028 0,45  
    0,359 0,51 2,3 2 
0,026 0,49  
    0,348 0,42 3,4 4 
0,021 0,58  
 
  
 In the presence of acceptor, a second (shorter) component appears, 
which is associated with the RB-631/anti-HSA complex. The effect of RB-631 
labeled anti-HSA and of anti-HSA on Ru-1/HSA are presented in figure 5-13. 
The decay time decreases with increasing RB-631/anti-HSA. At a molar ratio 
of RB-631/anti-HSA and Ru-1/HSA of 4:1 the decay time has decreased by 
29%. The fact that the changes are similar in intensity (figure 5-12) and 
decay time support the assumption that the intensity changes are due to 
energy transfer and not due to dynamic quenching by protein after 
antigen - antibody interaction. The changes in the decay time of Ru-1/HSA 
following association with the HSA-antibody, demonstrate that Ru-1 is a 
viable probe for decay time based immunoassay. 
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Fig. 5-13. Relative change in the decay time of Ru-1/HSA conjugate 
on addition of (a) RB-631/anti-HSA (__¾__¾__) and (b) non- labeled anti-
HSA (- -- -- - ), respectively, normalized to unity (t =  488 nm). 
(Concentration of Ru-1/HSA: 3.2 µM). 
5.2.4. Conclusion 
In this chapter, a resonance energy transfer immunosystem is introduced 
that undergoes changes in both emission intensity and decay time as a result 
of the formation of the Ag/Ab complex. 
 
 The fluorescent acceptor label used is water-soluble, displays a fairly 
large quantum yield (0.32) when covalently bound to proteins, a large molar 
absorbance (95,000  L/(mol· cm)). In the form of the reactive NHS ester it is a 
viable acceptor label for proteins, particularly for use in fluorescence energy 
transfer immunoassays. The spectral overlap of the absorption band of 
RB-631 with the emission maximum of Ru-1 at 639 nm makes the two dyes 
an efficient energy transfer pair. 
  
 The use of a ruthenium metal-ligand complex (MLC) as a donor in an 
energy transfer system enables immunoassays based on measurement of 
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decay times in the µs time regime. The close spatial proximity of donor and 
acceptor causes both the intensity and the decay time of the ruthenium 
donor to decrease. Decay time based assays using ruthenium MLCs are 
considered advantageous because of their long decay time and large Stokes’ 
shifts. It is known that the autofluorescence of biological samples is the main 
limitation for high sensitivity immunoassays. Autofluorescence typically decays 
within several nanoseconds and thus does not interfere with detection of the 
slow ruthenium MLC emission.  
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6. Hybridization systems 
 
In this chapter the application of the ruthenium metal-ligand complex Ru-1 for 
the use in DNA analysis is demonstrated. Ru-1 was covalently linked to the 5’ 
end of a 15mer oligonucleotide (A1). The properties of this labeled strand 
were investigated in terms of fluorescence intensity, lifetime and polarization.   
Furthermore, a hybridization study was performed. Therefore, the amino 
modief ied 3’ -  and 5 ’ - end of the complementary strand of Ru-1/A1 were 
covalent ly attached to a squar ine dye and the energy transfer was 
investigated occurring with hybridization. The efficiency of energy transfer 
was quant i f ied with f luorescence intensity measurements. 
 
6.1. Introduction 
The evaluation of the human genetic code and the development of new gene 
diagnostics show the importance of DNA in human life during the last years 
[1-3]. The hybridization analysis is a major field of interest in medical health 
and clinical diagnostics. Two methods are widely used, the hybridization on 
solid supports and in solution. Several approaches have been reported to 
couple the high specific biochemical reaction of hybridization to a sensing 
surface [4]. Electrochemical determination makes use of double strand 
specific ligands, which are electrochemically active [5]. High sensitivity was 
obtained using gold electrodes [6]. Other approaches use the piezoelectric 
effect [7]. However, homogenous hybridization assays in solution are faster 
[8]. More and more fluorescent labels have been investigated for DNA analysis 
via fluorescence energy transfer systems in liquid [9-16].  
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An ideal label for a DNA probe should fulfill the criteria of [17]: (a) to be 
easily attached to DNA, (b) to be detectable at very low concentrations, (c) to 
produce a signal that is changed when the labeled DNA probe hybridizes to its 
complementary DNA sequence, and (d) to be stable at the elevated 
temperatures conditions used in hybridization studies.  
In recent years, most FRET studies of nucleic acids have used 
fluorescein as the donor [18-20]. This fluorophore is easily excitable with a 
488 nm Argon ion laser, but exhibit a small Stokes’ shift of 25 nm, making 
separation of excitation and emission light very difficult.  
In this chapter the ruthenium MLC Ru-1 was used as the donor. This 
label has the advantage of a Stokes’ shift of more than 100 nm, thereby 
overcoming the problem of separating the excitation and emission light. The 
near-infrared dye RB-631 was used as acceptor for energy transfer. The 
optimal overlap of its excitation band at 631 nm with the emission band of 
Ru-1, the easy attachment to amino-modified oligonucleotides (oligos), in 
addition with the emission maxima in the optical window of blood makes this 
dye an optimal energy transfer partner for Ru-1.   
6.2. Methods and Materials 
The 15-mer oligos were purchased from Metabion GmbH (Munich, Germany) 
(see table 6-1). 
Table 6-1.  Properties of the oligos A1, A2 and A3. 
                  Strand MW e  
(260 nm) 
TT 
 / °C 
A1 5’-amino- CCG GCA GCA AAA TGT–3’ 153540 4571 47 
A2           3’- GGC CGT CGT TTT ACA–5’-amino 135700 4544 47 
A3 3’-amino- GGC CGT CGT TTT ACA–5’ 135700 4544 47 
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6. 2. 1. Dye label ing procedure 
Donor-labeled and acceptor-labeled DNA strands were prepared by reaction of 
the 5’- and 3’-amino oligos (A1, A2, A3) with the succinimidyl esters of Ru-1 
(A1) and RB-631 (A2 and A3). A 30-50 fold molar excess of dye, diluted in 
50 µL of DMF, was added to a 70 µg of oligonucleotide in 150 µL buffer 
(0.1 M NaHCO3, pH 9). Reactions were performed for 12 h in the dark at 
room temperature. To this mixture, 1 mL of cold ethanol was added to 
precipitate the oligo. The solution was centrifuged  three times and the 
ethanol was decanted to remove unreacted dye. The oligo was redissolved in 
100 µL of 15 mM citrate buffer (150 mM NaCl, pH 7) and washed again with 
ethanol three times. The dried oligo was stored at -20 °C. Labeled oligos were 
quantified by their 260 nm absorbances. The dye to oligo ratio was also 
determined by absorbance measurements. 
 
 
 Fig. 6-1. Ru-1- labeled A1 (left) and RB-631- labeled A2 (right) in the dry form. 
6.2.2. Hybrid izat ion procedure 
For the hybridization step the strand Ru-1/A1 was combined with strand A2. 
The same was performed with strand RB-631/A2 and RB-631/A3, 
respectively. For each series, a constant concentration of Ru-1/A1 (0.5 nM) 
was mixed with 0, 0.25, 0.5, 1.0, 2.5 and 5.0 nmol of the complementary 
strand and diluted to a constant volume of 600 µL with a 15 mM citrate 
buffer (150 mM NaCl, pH 7). These mixtures were heated to 65 °C for 2 h and 
cooled to 35 °C within 3 h. The following measurements were performed at 
35 °C using a thermostated heating bath. 
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6.3. Results 
6.3.1. The Ru-1 labeled o l igonucleot ide A1 
First, the properties of Ru-1/A1 were investigated in terms of fluorescence 
intensity, lifetime and polarization. Especially, the specific binding of Ru-1 to 
oligos was examined. Therefore, the oligo A1 was labeled on the one hand to 
the activated NHS ester of Ru-1 (Ru-1/A1), and on the other hand to the 
non-activated carboxy form of Ru-1 (Ru-1°/A1). The procedure for labeling was 
used as described in chapter 6.2. 
 
NRu2+CH3O
N
N
N
N
Ru
2+
N
N
CH3
CO N
H
O
P
 
  
Fig. 6-2. Schematic of the chemical structure of the Ru-1- labeled A1. 
 
Spectral characterization 
The emission spectra of Ru-1 dye in 15 mM citrate buffer (150 mM NaCl, 
pH 7) and Ru-1 labeled A1 are shown in figure 6-2. The emission maximum at 
610 nm undergoes a small shift to higher wavelengths if the dye is covalently 
bound to an oligo.  
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Table 6-2.  Spectroscopic properties of unlabeled  Ru-1°/A1 and the labeled  
 Ru-1/A1. 
Dye Abs.max. 
[nm] 
Em. max. 
[nm] 
Q.Y. Dye/Oligo 
[mol/mol] 
t  
[µs] 
P (25 °C) 
Ru-1°/A12 456 610 0,051 ___ 0,35 0,024 
Ru-1/A13 456 645 0,055 0,98 1,03 0,135 
[Ru(bipy)3]2+ 456 610 0,042 ___ ___ ___ 
 
The dye-to-oligo ratio was determined to be 0.98 at the absorption 
wavelengths of 260 nm and 456 nm for A1 and Ru-1, respectively. The 
quantum yields were measured with reference to the known quantum yield of 
[Ru(bipy)3]2+ (0.042). Similar quantum yields were found for the labeled Ru-1 
and the carboxylic form of Ru-1 (see table 6-2). In the following, the two 
mixtures Ru-1/A1 and Ru-1°/A1 were compared.  
 
Fig. 6-3. Emission spectra of free Ru-1 (____) and Ru-1 labeled to A1 (- -
- - )  in 15 mM citrate buffer (150 mM NaCl, pH 7). 
                                                 
2 Ru-1 covalently attached to the strand A1 
3 the unreactive carboxy form of Ru-1 and the strand A1 in buffer solution 
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Lifetime and polarization measurements 
The comparison of lifetime and polarization measurements of Ru-1°/A1 
(orange) and Ru-1/A1 (yellow) are shown in figure 6-4. The respective data are 
presented in table-6-2. The decay time of Ru-1°/A1 was double exponential 
with a main long delay of 360 ns (90%). The same was found for Ru-1/A1. 
However, it displays a three time longer decay time (1.1 µs, 75%) and a short 
component (280 ns). These differences in lifetime confirm in the first instance 
to a specific binding of the Ru-1-NHS ester to the amino group of the 15mer 
oligonucleotide A1.  
 The steady-state fluorescence polarization was investigated for both 
mixtures to verify the specific binding of Ru-1 to A1. Ru-1 exhibits in solution 
a small polarization, resulting from the high rotational freedom in solution. As 
expected, the polarization of Ru-1°/A1 with a value of 0.024 is also in the 
range of the free dye in solution. The Ru-1/A1 displays a five-fold increase in 
polarization, which confirms the specific binding of Ru-1 to the oligo. The high 
polarization value combined with the lifetime results and the data obtained for 
Ru-1°/A1 verify the covalent specific binding of Ru-1 to A1.  
 
Fig. 6-4. Comparison of the decay time and fluorescence polarization 
of Ru-1°/A1 and Ru-1/A1. 
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Hybridization study 
Hybridization studies were carried out by titration of Ru-1/A1 with the 
complementary strand of A1 using the hybridization procedure described in 
chapter 6.3. For emission intensity and lifetime measurements no signal 
change can be observed when adding the complementary strand. For 
polarization measurement there was also no significant signal change to 
higher values (5%). As a result, the system is not suitable for hybridization 
studies. 
6.3.2. Hybrid izat ion systems based on energy transfer 
The issue of location of the dye labeled to the complementary strand was 
investigated for hybridization. A 15mer oligo was used for this purpose, 
reported to be sufficiently short for energy transfer [21]. The complementary 
strands to A1 were amino-modified on the 3’-end (A3) and 5’-end (A2), 
respectively. The complementary strands A2 and A3 were labeled with the 
NHS activated squarine dye RB-631 to perform the energy transfer studies 
(see chapter 3.1.2).  
 
Spectral characterization of the complementary strands to A1 
Several spectral data measured for the complementary strands RB-631/A2 
and RB-631/A3 are listed in table 6-3. Absorption and emission maxima of 
RB-631 exhibit a bathochromic shift when covalently bound to the 
oligonucleotides A2 and A3. The quantum yields of the dyes labeled to the 
oligos were five times higher than the quantum yield of the unlabeled dye. The 
dye-to-oligo ratio was determined by absorbance measurement and was found 
to be 0.16 and 0.19 for the oligo A2 and A3, respectively. The requirements 
for the dye in energy transfer studies were found to be similar to the energy 
transfer HSA immunosystem and were discussed in chapter 5. 
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Table 6-3.  Characterization of the RB-631 modified strands A2 and A3. 
Dye Abs. max. 
[nm] 
Em. max. 
[nm] 
Q.Y. Dye/Oligo 
[mol/mol] 
RB-631 631 645 0.04 ___ 
RB-631/A2 635 658 0.19 0.16 
RB-631/A3 635 658 0.22 0.19                                                                                             
Cy5* 647 664 0.25 ___ 
  * used as reference standard 
 
Hybridization systems Ru-1/A1 – RB-631/A2 and Ru-1/A1 – RB-631/A3 
Two titration experiments were carried out where fixed quantities of Ru-1/A1 
were titrated with increasing amounts of the complementary strand of A1. 
The complementary strands A2 and A3 were labeled on the 3’-end terminus 
and 5’- terminus with RB-631, respectively. The two hybridization systems 
are illustrated in figure 6-5. The hybridization was performed as described in 
chapter 6.3.  
 Figure 6-6 and figure 6-7 present the two titration experiments. In both 
titrations the Ru-1 emission decreased with increased amounts of acceptor 
labeled oligomer until a ratio of acceptor labeled oligomer to Ru-1-oligomer 
close to 5 was reached. The emission intensity was constant at ratios of 
complementary oligomers larger than 5. The optimal energy transfer was 
expected at a complex with a 1:5 ratio, because the dye to oligo ratios of the 
labeled complementary strands were 0.16 and 0.19 for A2 and A3, 
respectively. Therefore, approximately 80% unlabeled complementary strand 
were in hybridization solution and a five fold excess of the complementary 
strand was necessary to saturate the energy transfer system.  
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 Fig. 6-5. Schematic illustration of the energy transfer systems Ru-1/A1 –  
 RB-631/A2 and Ru-1/A1 – RB-631/A3. 
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Fig. 6-6. Luminescence energy transfer in the system A1/A2: The 
strand Ru-1/A1 (dye/oligo = 0.98) of constant concentration 
(8.3  µM) was titrated with the strand RB-631/A2 (dye/oligo = 0.16); 
( lex= 460 nm). 
  
 
Fig. 6-6. Luminescence energy transfer in the system A1/A2: The 
strand Ru-1/A1 (dye/oligo = 0.98) of constant concentration (8.3 µM) 
was titrated with the strand RB-631/A3 (dye/oligo = 0.19);  
(lex= 460 nm). 
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To compare the two energy transfer systems, the fluorescence intensity was 
measured and the ratios of the two emission maxima at 639 nm (donor) and 
651 nm (acceptor) were determined. In figure 6-8 the normalized ratios of the 
intensities are plotted against the ratio of RB-631/A2 (A3) and Ru-1/A1. As 
can be seen, the energy transfer efficiency of the system with the 
complementary strand A3 is more expressed than for the system with the 
A2 strand. These results can be explained by the closer distance of the donor 
and acceptor dye by attaching the donor at the 5’-end of a 15mer oligo, and 
the acceptor at the 3’-end of the complementary strand. The linkage of the 
acceptor dye at the 5’-end of the complementary strand results in an energy 
transfer that differs in the efficiency. 
 
 
Fig. 6-7. Comparison of the energy transfer efficiency of the 
hybridization systems Ru-1/A1 RB-631/A2 (- - - - - - - ) and Ru-1/A1 
RB-631/A3 (______). 
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6.4. Conclusion 
In this chapter it is demonstrated that Ru-1 can be coupled to 5’-NH2-
modified oligos. Due to the linkage to the oligonucleotide, the fluorescence 
decay time and the steady-state fluorescence polarization of the complexes 
increased. The hybridization with the unlabeled complementary strand did not 
change the Ru-1 intensity.  
Ru-1 as donor label in combination with the near-infrared acceptor label 
RB-631 turned out to be a very useful donor-acceptor pair for performing 
hybridization studies by non-radiative fluorescence energy transfer. The 
attachment of RB-631 to the 5’ and 3’ ends of the complementary strands of 
the Ru-1-modified oligo were carried out when coupling the NHS ester of 
RB-631 to the amino-modified complementary strands. Upon hybridization of 
the complementary strand (A2, A3) modified with RB-631 at the 5’- and 3’- 
end with the Ru-1 modified oligo, a decrease in Ru-1 emission intensity and an 
enhancement in RB-631 emission was observed. In conclusion, the energy 
transfer occurs in both systems, but the attachment of the donor at the 5’-
end and the acceptor at the 3’ end of the complementary strands is more 
efficient. This is interpreted in terms of a closer distance of both dyes after 
hybridization. 
The use of Ru-1 for primers can also be taken in consideration, because 
of the excitation that is possible at 488 nm, which is often used for standard 
primer dyes like fluorescein and rhodamine. The emission intensity of Ru-1 at 
610 nm makes this dye an additional opportunity for multiplex analysis. 
Another possibility is to introduce  Ru-1 modified oligos in flow cytometry, 
using an argon ion laser routinely. 
Chapter 6: Hybridization system 
 
page 94 
6.5. References 
[1] Ewin B., Green P., Nature Genet. 2000, 25, 232. 
[2] Liang F., Holt I., Pertea G., Karamycheva S., Salzberg S.L., 
Quackenbush J. Nature Genet. 2000, 25, 239. 
[3] Hattori M. et.al., Nature 2000, 402, 311. 
[4] Kleinjung F., Bier F. F., Warinke A., Scheller F. W., Anal. Chim. Acta 
1997, 350, 71. 
[5] Millan K. M., Saraoullo A., Mikkelsen S. R., Anal. Chem. 1993, 65, 
2317. 
[6] Steel A. B., Herne T. M., Tarlov M. J., Anal. Chem. 1998, 70, 4670. 
[7] Su H., Kallury K. M. R., Thompson M., Roach A., Anal. Chem. 1994, 
66, 769. 
[8] Ishiguro T., Saitoh J., Yawata H., Otsuka M., Inoue T., Sugiura Y., 
Nucleic Acids Res. 1996, 24, 4992. 
[9] Norman D. G., Graininger R. J., Uhrin D., Lilley D. M. J., Biochemistry 
2000, 39, 5317. 
[10] Hu X., Gregory D. S., Sykora M., Lee S. J., Grinstaff M. W., Inorg. 
Chem. 2000, 39, 2500. 
[11] Mergny J. L., Biochemistry 1999, 38, 1573. 
[12] Stühmeier F., Welch J. B., Murchie A. I. H., Liley D. M. J., Clegg R. 
M., Biochemistry 1997, 36, 13530. 
[13] Clegg R. M., Murchie A. I. H., Zechel A., Carlberg C., Diekmann S., 
Lilley D. M. J., Biochemistry 1992, 31, 4846. 
[14] Kelley S. O., Barton J. K., Science 1999, 283, 375. 
[15] Yang M., Ren L.-Q., Huang M., Kong R. Y. C., Fong F. W., Anal. 
Biochem. 1998, 259, 272. 
[16] Grinstaff M. W., Angew. Chem., Int. Ed. Engl. 1999, 38, 3629. 
[17] Matthews J. A., Kricka L. J., Anal. Biochem. 1988, 169, 1. 
Chapter 6: Hybridization system 
 
page 95 
[18] Parkhurst K. M., Parkhurst L. J., Biochemistry 1995, 34, 293. 
[19] Morrison H. E., Halder T. C., Stols L. M., Anal. Biochem. 1989, 183, 
231. 
[20] Yang M., Millar D. P., Biochemistry 1996, 35, 7959. 
[21] Ju J., Kheterpal I., Scherer J. R., Ruan C., Fuller C. W., Glazer A. N., 
Mathies R. A., Anal. Biochem. 1995, 231, 131. 
 
Chapter 7 : Experimental Part 
 
page 96 
7. Experimental Part 
 
7.1. General Remarks 
7.1.1 Chemicals, Proteins and Buffers 
All chemicals and solvents used were obtained from Merck (Darmstadt, 
Germany), Aldrich (Steinhein, Germany) and Fluka (Buchs, Switzerland). All 
chemicals were analytical grade and were used as received. Cy5 was obtained 
from Amersham Life Science (Pittsburgh, USA). DPPC, PE, HSA and anti-HSA 
were obtained from Sigma (Germany). Ru-(phen)2-(C16)2 was synthesized by 
Roche (Penzberg, Germany). Fluorescein-NHS was a gift from Roche 
(Penzberg, Germany). Anhydrous diethylether and anhydrous DMF were 
prepared, according to a standard procedures published in [1]. 
Ethylenediamine was freshly distilled. Water was double distilled. 
Phosphate buffer of pH 7.2, 0.1 M: 3.17 g of NaH2PO4· H2O and 13.7 g 
of Na2HPO4· 2 H2O were dissolved in 1 L of double distilled water. Bicarbonate 
buffer of pH 9.0, 0.05 M: 2.1 g of NaHCO3 were dissolved in 500 mL of double 
distilled water. The buffers were adjusted to the corresponding pH value with 
0.1 N HCl and 0.1 N NaOH, respectively. 
7.1.2 Chromatography 
For analytical thin-layer chromatography (TLC), RP-18 F254 aluminium sheets 
(thickness 0.2 mm) for polar solvents, and silica gel 60 F254 aluminium sheets 
(thickness 0.2 mm) for non-polar solvents were used. They all were purchased 
from Merck (Darmstadt, Germany). 
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Medium pressure liquid chromatography (MPLC) was carried out on a 
Büchi 681 MLC apparatus. The column length was 26 cm with a diameter of 2 
cm, the pre-column was 13 cm long with a diameter of 2 cm. For non-polar 
substances, both, pre-column and column were filled with Europrep 60-20, 
60 Å, 15-25 mm (irregular) from Knauer. For polar substances, the pre-
column was filled with Europrep 60-60-C18 and the main column was filled 
with Europrep 60-20-C18 from Knauer.  
Gel permeation chromatography was carried out using Sephadex G25 
(coarse) from Pharmacia (Uppsala, Sweden) as the stationary phase 
(0.5 x 20 cm column) and a 22 mM phosphate buffer solution (pH 7.2) as the 
eluent. 
7.1.3 Analysis and Spectroscopy 
Melting points were measured with an apparatus SMP-20 from Büchi and 
were not corrected. pH values were measured at room temperature with a 
pH meter WTW 538 (Weilheim, Germany). UV spectra were recorded with a 
U-3000 spectrophotometer from Hitachi. Emission spectra were acquired 
with a luminescence spectrometer Aminco (Series 2) from SLM with a 
standard 150 W xenon lamp as the excitation source and with a multi 
frequency fluorimeter K2 from ISS with a argon ion laser (488 nm) or a 
standard 300 W xenon lamp as the excitation sources. Fluorescence lifetimes 
and polarization measurements were measured with a multi frequency 
fluorimeter K2 from ISS with a argon ion laser (488 nm) and standard 300 W 
xenon lamp as the excitation source, respectively. 
1H-NMR spectra were recorded with a 250 MHz PFT-NMR 
spectrometer (AC 250 from Bruker). The internal standard used was TMS. 
The chemical shifts are given in ppm. The following abbreviations were used to 
describe the signals: s = singlet, d = doublet, dd = double of doubletts, t = 
triplet, q = quartett, m = multiplet, br = broad peak. Mass spectra were 
recorded with a Finnigan MAT 95 (fast-atom bombardment, FAB and chemical 
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ionization, CI) and a Finnigan MAT 311 A (electron impact EI) at the University 
of Regensburg.  
7.1.4 Determination of the Molar Absorbance 
The dyes (~0.55 mg) were dissolved in 100 mL of doubly distilled water. From 
this stock solution, three dilutions (1:20, 1:50, 1:100) were made and the 
molar absorbance was measured. The extinction coefficients were calculated 
according to Lambert-Beer’s law (E = e ·  c ·  d). 
7.1.5 Determination of Quantum Yields [2] 
The quantum yields of the dyes and the dye-protein conjugates were measured 
in phosphate buffer (22 mM, pH 7.2) relative to a reference fluorophor with a 
known quantum yield. These references were Cy5 (Amersham) for RB-631 and 
with a quantum yield of 0.28 in PBS [3] and Ru(bipy)32+ for the ruthenium 
MLCs with a quantum yield of 0.042 [4] in ethanol. The following formula is 
used to determine the quantum yields: 
jS = jRef ·  (ERef/ES) ·  (AS/ARef) ·  (n2S/n2Ref),     (7-1) 
where 
jS is the quantum yield of the substance to determine, 
jRef is the quantum yield of the reference, 
E is the absorbance at the excitation wavelength of the substance to 
determine, 
ERef is the absorbance at the excitation wavelength of the reference, 
A is the integrated area of the fluorescence spectrum of the 
substance to determine, 
ARef is the integrated area of the fluorescence spectrum of the 
reference, 
n2S is the refractive index of the solvent for the substance to 
determine, 
n2Ref is the refractive index of the solvent for the reference. 
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The quantum yield was determined as follows: 
(1) The absorbance spectra of sample and reference are measured (the 
extinction of the solutions must be lower than 0.1 to avoid the inner 
filter effect). 
(2) The emission spectra of sample and reference are measured (excitation 
of sample and reference must be at the same wavelength). 
(3) Integration of the areas of the emission spectra. 
(4) The quantum yield was then determined via the formula above 
7.2. Syntheses and Purification of the Dyes 
7.2.1. Ruthenium metal-l igand complexes 
7.2.1.1. Synthesis of the Ru-(bipy)2-mcbpy (Ru-1) 
Ø 4´-Methyl-2,2´-bipyridine-4-carboxaldehyde [5] 
 
 
SeO2 (1.74 g, 15.7 mmol) was added to a solution of 4,4´-dimethyl-2,2´-
bipyridine (2.64 g, 14.3 mmol) in 75 mL dioxane and refluxed for 24 h. The 
solution was then filtered hot, and the dioxane was removed by rotary 
evaporation. Next the residue was dissolved in ethyl acetate and filtered to 
remove additional solid material. The ethyl acetate layer was subsequently 
extracted with 1 M Na2CO3 (2 x 100 mL) to remove additional carboxylic acid 
and 0.3 M Na2S2O5 (3 x 100 mL) to form the aldehyde bisulfite. The combined 
aqueous extracts were adjusted to pH 10 with Na2CO3 and extracted with 
CH2Cl2 (4 x 100 mL). The organic phases were collected and evaporated.  
Yield: 1.75 g (62%), white powder, C12H10N2O (198.22 g/mol). 
m.p.: 131°C. 
NN
CH3 CH3
NN
CH3 CHO
SeO2
Dioxan
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1H-NMR (CDCl3, TMS external, 250 MHz): d 2.45 (s, 3 H); 7.15-8.8 (m, 6 H); 
10.1 (s, 1 H). 
 
Ø 4´-Methyl-2,2´-bipyridine-4-carboxylic acid [6] 
 
A solution of AgNO3 (1.57 g, 9.24 mmol) in 16 mL water was added to a 
suspension of 4´-Methyl-2,2´-bipyridine-4-carboxaldehyde (1.75 g, 
8.83 mmol) in 75 mL 95% ethanol. The suspension was stirred rapidly, and 
40 mL 1 M NaOH was added dropwise over 20 min to form Ag2O. The dark 
black solution was stirred for an additional 15 h. Finally, the ethanol was 
removed by rotary evaporation, and the remaining water solution was filtered 
to remove Ag2O. The residue was washed with 1.3 M NaOH (2 x 20 mL) and 
20 mL H2O. The combined filtrates were extracted with CH2Cl2 to remove 
unreacted aldehyde and adjusted to pH 3.5 with 1:1 (v/v) 4 N HCl:AcOH to 
afford a white compound. The product precipitated overnight at -10 °C, and 
the compound was collected. 
Yield: 1.26 g (67%), white powder, C12H10N2O2 (214.22 g/mol). 
m.p.: 280°C. 
1H-NMR (CDCl3, TMS external, 250 MHz): d 2.5 (s, 3 H); 7.15-9 (m, 6 H). 
 
NN
CH3 CHO
NN
CH3 COOH
AgNO3
Chapter 7 : Experimental Part 
 
page 101 
Ø Ruthenium-bis(2,2´-bipyridine)- ( 4´-methyl-2,2´-bipyridine-4-carboxylic 
acid)-  
        bis(hexafluorophosphate) (Ru-1) [6] 
 
 
Ru-(bipy)2Cl2 (0.3 g, 0.57 mmol) was added to a solution of 4´-methyl-2,2´-
bipyridine-4-carboxylic acid (0.15 g, 0.58 mmol) in 25 mL 70% ethanol/H2O 
and refluxed for 10 h. Next, the reaction mixture was cooled and ethanol was 
removed in vacuum. After standing for 4 h at room temperature, the solution 
was filtered and the solid compound washed with cold water. A saturated 
aqueous solution of NH4PF6 was added until no further precipitate was 
observed. The mixture was kept at room temperature for an additional 2 h and 
then finally filtered washed with cold water and ether, and dried overnight.  
Yield: 0.42 g (81%), orange pwoder, C32H26F12N6O2P2Ru (917.6 g/mol). 
m.p.: > 250°C. 
Rf (RP-C18, methanol:water 2:1 v/v): 0.55. 
FAB-MS: m/e (M - 2H+, dianion) for C32H26N6O2Ru calcd. 738.9, found 738.6. 
7.2.1.2.  Synthesis of the Ru-(bipy)2-dcbpy (Ru-2) 
Ø 2,2´-  bipyridine-4,4´-dicarboxylic acid [7-9] 
 
NN
CH3 CH3
NN
COOHCOOH
CrO3
conc. H2SO4
NN
COOH CH3
[Ru(bpy)2]Cl2
(NH4)PF6
N
N
N
N
Ru
2+
N
N
CH3
COOH
(PF6
-)2
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1.0 g (5.2 mmol) of 4,4´-dimethylbipyridyl is solved in 200 mL conc. H2SO4 and 
cooled to 0 °C. Then 3.3 g (33 mmol) CrO3 is added in four portions. The 
solution is then stiffed for 4 h at 75 °C, and then 12 h at room temperature. 
The reaction mixture is added to 2 L ice water. The formed precipitate was 
centrifugated and washed three times with water. The white precipitate is 
solved in KOH and then precipitated with conc. HCl. The precipitate was 
collected by filtration and washed with water, methanol and diethyl ether. 
Yield: 1.0 g (75%), white powder, C12H8N2O4 (244.21 g/mol). 
m.p.: > 250°C. 
FAB-MS: m/e (M - H+, dianion) for C12H8N2O4 calcd. 243.2, found 242.9. 
Ø Ruthenium-bis(2,2´-bipyridine)- (2,2´-  bipyridine-4,4´-dicarboxylic acid)-  
         bis(hexafluorophosphate) (Ru-2) 
 
0.1 g (0.21 mmol) Ru(bpy)2Cl2, 0.1 g NaHCO3 and 0.08 g (0.3 mmol) 2,2´-
bipyridine-4,4´dicarboxylic acid are heated in MeOH: H2O (v/v) 4:1 for 10 h. 
The solution is cooled in an ice bath for 2 h, and the pH is adjusted with 
concentrated H2SO4 to 4. The formed precipitate is filtered and washed with 
MeOH. The filtrate is treated with 5 g NaPF6 in 25 mL H2O, then cooled in an 
ice bath, and the precipitate is collected by filtration. 
Yield: 0.13 g (67%), violett crystals, C32H24F12N6O4P2Ru (948.22 g/mol). 
m.p.: > 250°C. 
Rf (RP-C18, methanol:water 1:1 v/v): 0.6. 
FAB-MS: m/e (M - H+, dianion) for C32H24N6O4Ru calcd. 947.2, found 946.8. 
NN
COOH COOH
[Ru(bpy)2]Cl2
(NH4)PF6
N
N
N
N
Ru
2+
N
N
COOH
COOH
(PF6
-)2
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7.2.1.3. Synthesis of the Ru-(bipy)2-mcbpy membrane probes (Ru-1-R) 
Ø Ru-1-NHS 
 
Ru-1 (50 mg, 55 µmol) and 10 mg (86 µmol) of N-hydroxysuccinimide (NHS) 
were dissolved in 1 mL of acetonitrile at room temperature. N,N’-
dicyclohexylcarbodiimide (DCC, 17 mg, 83 µmol) was then added. The mixture 
was sealed and stirred for 5 h. The formed precipitate was removed by 
filtration through a syringe filter and the filtrate was added to a stirring 
solution of 2-propanol. The mixture was kept at -4 °C for 1 h. The precipitate, 
Ru-1-NHS was collected by filtration and washed with dry ether (3 x 5.5 mL). 
Yield: 44 mg (30%), blue crystals, C38H46N2O10S2 (740.88 g/mol). 
m.p.: > 250°C. 
Rf (RP-C18, methanol:water 2:1 v/v): 0.55. 
FAB-MS: m/e (M - 2H+, dianion) for C37H42N2O10S2 calcd. 738.9, found 738.6. 
 
Ø Ru-1-R 
 
N
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N
N
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Ru-1-NHS (50 mg, 49 µmol) and the lipid (80 µmol) were dissolved in 1.5 mL 
dry chloroform under nitrogen atmosphere. Then 10µL of NEt3 was added. The 
mixture was stirred for 20 h in the dark. The solvent was evaporated in 
vacuum and the residue purified by medium pressure liquid chromatography on 
a column of silica gel-60 (230-400 mesh), with a mixture of chloroform-
methanol-water as the eluent.   
 
Ø Ru-1-PE 
 
Yield: 15 mg (20%), orange crystals, C69H96 F12N7O9P3Ru (1591.6 g/mol). 
m.p.: > 250°C. 
Rf (silica gel, chloroform:methanol:water 65:25:4 v/v): 0.55. 
1H-NMR (CDCl3, TMS external, 250 MHz): d = 0.87 (m, 6 H); 1.24 (s, 48 H); 
1.39 – 1.57 (m, 4 H); 2.25 – 2.31 (m, 4 H); 2.6 (m, 2 H); 3.57 (m, 2 H); 4.1 – 
4.21 (m, 5 H); 4.4 (dd, J1= 3.1, J2=11.5, 2 H); 5.23 – 5.25 (m, 1 H); 7.41 – 
7.52, 7.64 – 7.72, 8.0 – 8.1, 8.4 – 8.7 (m, 22 H).   
31P-NMR (CDCl3):  d = 2.7; -143 ppm.  
 FAB-MS: m/e (M2+) for C69H96N7O9Ru calcd. 1301.4, found 1300.4 
N
N
N
N
Ru
2+
N
N
CO
CH3
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Ø Ru-1-C16H33 
 
Yield: 4.5 mg (9%), orange crystals, C48H59F12N7OP2Ru (1141.6 g/mol). 
m.p.: > 250°C. 
Rf (silicagel, chloroform:methanol 3:1 v/v): 0.75. 
1H-NMR (CDCl3, TMS external, 250 MHz): d 0.87 (t, J = 6.83, 3 H); 1.23 (s, 
28 H); 1.61 – 1.83 (m, 3 H); 3,42 (m, 2 H); 7.42 – 7.47, 7.65 – 8.05, 8.40 – 
8.43 (m, 22 H).   
31P-NMR (CDCl3):  d = -143 ppm.  
 FAB-MS: m/e (M2+) for C48H59N7ORu calcd. 851.2, found 851.4. 
Ø Ru-1-C18H37 
 
Yield: 9 mg (17%), orange crystals, C50H63F12N7OP2Ru (1169.6 g/mol). 
m.p.: > 250°C. 
Rf (silicagel, chloroform:methanol 3:1 v/v): 0.75. 
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1H-NMR (CDCl3, TMS external, 250 MHz): d 0.87 (t, J = 6.62, 3 H); 1.23 (s, 
32 H); 1.61 – 1.83 (m, 3 H); 3,42 (m, 2 H); 7.42 – 7.47, 7.65 – 8.05, 8.40 – 
8.43 (m, 22 H).   
31P-NMR (CDCl3):  d = -143 ppm.  
 FAB-MS: m/e (M2+) for C50H63N7ORu calcd. 879.2, found 878.5. 
 
7.2.1.3.  Synthesis of the Ru-(bipy)2-dcbpy membrane probes (Ru-2-R2) 
 
Ru-2 (19 mg; 20 µmol), lipid (50 µmol) and 4-(dimethylamino)pyridine (2.4 mg; 
20 µmol) were suspended in 3 mL of CHCl3 and stirred in an ice bath.  Then, 
1-ethyl-3-(3-(di-methylamino)propyl) carbodiimide hydrochloride (9 mg; 
58 µmol) was added, and the reaction mixture kept at 0 °C for 2 h and 
afterwards for two days at room temperature.  The solvent was evaporated in 
vacuum and the residue purified by medium pressure liquid chromatography on 
a column of silica gel-60 (230-400 mesh), with a mixture of chloroform-
methanol-water as the eluent.   
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Ø Ru-2-PE2 
 
Yield: 11 mg (22%), orange crystals, C106H166 F12N8O18P4Ru (2298 g/mol). 
m.p.: > 250°C. 
Rf (silica gel, chloroform:methanol:water 65:25:4 v/v): 0.7. 
1H-NMR (CDCl3, TMS external, 250 MHz): d = 0.83 (t, J = 6.28, 12 H); 1.23 
(s, 96 H); 1.48 – 1.65 (m, 8 H); 2.15 – 2.31 (m, 8 H); 3.1 (t, J = 4.28, 4 H); 
3.94 – 4.23 (m, 10 H); 4.36 (dd, J1= 2.89, J2=12,01, 2 H); 5.12 – 5.24 (m, 
2 H); 7.35 – 7.5, 7.6 – 7.8, 7.9 – 8.2, 8.45 – 8.6 (m, 22 H).   
31P-NMR (CDCl3):  d = 0.23; -143.   
FAB-MS: m/e (M2+) calcd. for C106H166N8O18P2Ru: 2003.2, found 2003.5.   
 
Ø Ru-2-(C16H33)2 
 
Yield: 9 mg (30%), orange crystals, C64H90 F12N8O2 P2Ru (1395.2 g/mol). 
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m.p.: > 250°C. 
Rf (silica gel, chloroform:methanol:water 65:25:4 v/v): 0.8. 
1H-NMR (CDCl3, TMS external, 250 MHz): d  0.88 (t, J = 6.85, 6 H); 1.24 (s, 
52 H); 1.61 – 1.83 (m, 4 H); 3.21 (q, J1= 7.01, J2=12,91, 4 H); 7.42 – 7.47, 
7.65 – 8.05, 8.40 – 8.43 (m, 22 H).   
31P-NMR (CDCl3):  d = -143 ppm.   
FAB-MS: m/e (M2+) for C64H90N8O2Ru calcd. 1104.3, found 1104.5. 
 
Ø Ru-2-(C18H37)2 
 
Yield: 11 mg (33%), blue crystals, C68H98F12N8O2 P2Ru (1450.32 g/mol). 
m.p.: > 250°C. 
Rf (silica gel, chloroform:methanol:water 65:25:4 v/v): 0.8. 
1H-NMR (CDCl3, TMS external, 250 MHz): d 0.89 (t, J = 6.85, 6 H); 1.22 (s, 
68 H); 1.63 – 1.81 (m, 4 H); 3.21 (q, J1= 6.95, J2=12,52, 4 H); 7.43 – 7.47, 
7.66 – 8.01, 8.38 – 8.41 (m, 22 H).   
31P-NMR (CDCl3):  d = -143 ppm.  
 FAB-MS: m/e (M2+) for C68H98N8O2Ru calcd. 1159.2, found 1160.6. 
N
N
N
N
Ru
2+
N
N
CO
CO N
H
C18H37
C18H37NH
(PF6
-)2
Chapter 7 : Experimental Part 
 
page 109 
7.2.2. Fluorescein membrane probes Fl-R 
 
Fluorecein-NHS (10 mg, 21 µmol) and the lipid (27 µmol) were dissolved in 
1.5 mL dry chloroform under nitrogen atmosphere. Then 10µL of NEt3 was 
added. The mixture was stirred for 20 h in the dark. The solvent was 
evaporated in vacuum and the residue purified by medium pressure liquid 
chromatography on a column of silica gel-60 (230-400 mesh), with a mixture 
of chloroform-methanol as the eluent.   
Ø Fl-PE 
O OHO
COOH
PE
O
NH
 
Yield: 6 mg (52%), orange crystals, C58H84NO14P (1050.1 g/mol). 
m.p.: > 250°C. 
Rf (silica gel, chloroform:methanol:water 65:25:4 v/v): 0.8.  
 FAB-MS: m/e (M-H+) for C58H84NO14P calcd. 1049.1, found 1048.8. 
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Ø Fl-C16H33 
O OHO
COOH
C16H33
O
NH
 
Yield: 8 mg (60%), orange crystals, C37H45NO6 (599.01 g/mol). 
m.p.: > 250°C. 
Rf (silica gel, chloroform:methanol:water 65:25:4 v/v): 0.65.  
 FAB-MS: m/e (M-H+) for C37H45NO6 calcd. 598.0, found 598.5. 
Ø Fl-C18H37 
 
Yield: 6 mg (52%), orange crystals, C39H49NO6 (628.9 g/mol). 
m.p.: > 250°C. 
Rf (silica gel, chloroform:methanol:water 65:25:4 v/v): 0.65.  
 FAB-MS: m/e (M-H+) for C37H45NO6 calcd. 627.9, found 628.5. 
O OHO
COOH
C18H37
O
NH
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7.2.3. Squaryl ium dye RB-631 
7.2.3.1. 1-Ethyl-2,3,3-tetramethylindoleninium-5-sulfonate [10] 
 
1.1 g (4.0 mmol) of potassium 2,3,3-trimethylindolenine-5-sulfonate are 
suspended in 30 mL of ethyl iodide. The reaction mixture is heated to boiling 
for 25 h in a sealed tube. After cooling, excess ethyl iodide is decanted and 
the residue is suspended in 50 mL of acetone and stirred at room 
temperature for 20 min. The solution is filtered, the residue is washed with 
acetone and ether and dried in a desiccator over CaCl2. 
Yield: 912 mg (90%), light pink powder, C13H17NO3S (267.31 g/mol). 
m.p.: 215-217°C 
Rf (silica gel; 2-propanol:water:ammonia 9:1:1 v/v): 0.30. 
1H-NMR (d6-DMSO, TMS external, 250 MHz): d 8.05 (s, 1H), 7.65 (d, 1H), 
7.45 (d, 1H), 3.95 (s, 3H) 2.75 (s, 3H), 1.55 (s, 6H). 
 
7.2.3.2.1-[1-[5-Carboxypentyl]-3,3-dimethyl-5-sulfo-2-indolinylidene 
methyl]-2-butoxycyclobutene-3,4-dione [11] 
 
0.5 g (1.4 mmol) of 1-(5-carboxypentyl)-2,3,3-trimethylindoleninium-5-
sulfonate are dissolved in 20 mL of ethanol containing 1 mL of triethylamine. 
Then 325 µL (1.5 mmol) of squaric acid dibutyl ester are added slowly. The 
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mixture is warmed to 60 °C and stirred for 6 h. Then another 50 µL of squaric 
acid dibutyl ester are added and the mixture is refluxed for 2 h. After cooling 
to room temperature, the solvent is removed under reduced pressure. The 
yellow residue is dissolved in 20 mL of water and extracted three times with 
20 mL of chloroform. The aqueous phase is collected and the water is 
removed on a rotary evaporator. The yellow amorphous residue is triturated 
with ether and stirred over night at room temperature until the product 
crystallizes. The raw product is recrystalized from 2-butanol. 
Yield: 355 mg (50%), orange powder, C25H31NO8S (505.58 g/mol). 
m.p.: 105°C (decomp.). 
Rf (RP-18, methanol:water 2:1 v/v): 0.50. 
1H-NMR (D2O, TMS external, 250 MHz): d 7.65 (m, 2H), 7.05 (d, 1H), 5.35 
(s, 1H), 4.60 (t, 2H), 3.75 (t, 2H), 2.2 (m, 2H), 1.65-1.15 (m, 10H), 1.40 (s, 
6H), 1.15 (t, 3H). 
FAB-MS: m/e (M + H+, cation) for C25H32NO8S, calcd. 506.6, found 506.3. 
UV: l (H2O) = 432 nm. 
 
7.2.3.3. RB-631-butylester [11] 
 
100 mg (0.20 mmol) of 1-[1-[5-carboxypentyl]-3,3-dimethyl-5-sulfonic acid-2-
indolinylidenemethyl]-2-butoxycyclobutene-3,4-dione and 50 mg (0.20 mmol) of 
1-ethyl-2,3,3-tetramethylindoleninium-5-sulfonate are dissolved in 50 mL of a 
1-butanol/toluene mixture (1:1 v/v) and are refluxed for 10 h using a Dean-
Stark trap. After cooling, the solvents are removed under reduced pressure. 
The product is purified by MPLC using Europrep 60-20-C18 as the stationary 
phase and a methanol:water mixture (60:40 v/v) as the eluent. 
Yield: 44 mg (30%), blue crystals, C38H46N2O10S2 (740.88 g/mol). 
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Rf (RP-C18, methanol:water 2:1 v/v): 0.55. 
FAB-MS: m/e (M - 2H+, dianion) for C37H42N2O10S2 calcd. 738.9, found 738.6. 
 
7.2.3.4. RB-631 [12] 
 
16 mg (21 µmol) of RB-631-butylester are dissolved in 1 mL of water, and 
10 mL of 0.1 N HCl are added. The mixture is refluxed for 1.5 h. At the end of 
the reaction, 5 mL of 1 N HCl are added. After cooling, the solvent is 
removed, the product is washed with ether, and dried in the vacuum of an oil 
pump. 
Yield: 40 mg (98%), blue crystals, C33H36N2O10S2 (684.77 g/mol). 
m.p.: > 250°C. 
Rf (RP-C18, methanol:water 2:1 v/v): 0.70. 
1H-NMR (D2O, TMS external, 250 MHz): d 7.70-7.55 (m, 4H), 7.20-7.00 (m, 
2H), 5.50 (s, 1H), 5.40 (s, 1H), 4.45 (t, 2H, J=6.5 Hz), 4.00 (s, 3H), 2.05-
2.30 (m, 2H), 1.50-1.25 (m, 6H), 1.20 (t, 12H). 
FAB-MS: m/e (M - 2H+, dianion) for C34H36N2O10S2 calcd. 682.8, found 682.7. 
 
7.2.3.5. RB-631-NHS-ester [13] 
 
10 mg (14.6 µmol) of RB-631, 4.5 mg (22 µmol) of dicyclohexylcarbodiimide 
and 2.5 mg (22 µmol) of N-hydroxysuccinimide are dissolved in 0.5 mL of dry 
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DMF and 10 µL of triethylamine. The solution is stirred for 16 h at room 
temperature. Then, the reaction mixture is filtered over a filter syringe and 
washed with anhydrous DMF. The solvent is removed in vacuum and the 
product is tritrated with anhydrous ether until it crystallizes. The solvent is 
decanted and the blue crystals are dried in a desiccator over CaCl2. 
Yield: 8 mg (70%), blue powder, C38H41N3O12S2 (781.84 g/mol). 
m.p.: > 250°C. 
Rf (RP-18, methanol:water 2:1 v/v): 0.65. 
FAB-MS: m/e (M - 2H+, dianion) for C37H37N3O12S2, calcd. 781.8, found 781.9. 
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Summary 
This thesis describes the synthesis and spectral characterization of novel 
dyes for HSA labeling, DNA labeling and MLC membrane probes. The dyes 
were especially quantified in case of suitability as labels and probes in 
biological systems.  
 Chapter 1 gives a short overview of the importance of fluorescent 
markers in life science. Chapter 2 introduces the measurement background of 
lifetime, fluorescence RET and steady-state polarization. 
 
 In chapter 3 the syntheses and spectral characterization of the dyes 
are described. Two classes of dyes were synthesized.  
 The first class of dyes were labels for the use as suitable markers in 
bioassays. A ruthenium ligand complex and a squarine dye are synthesized for 
steady-state polarization and energy transfer studies. These two labels were 
converted into reactive NHS esters by the standard NHS/DCC procedure to 
make them amino-reactive for covalent coupling to protein or oligonucleotides.  
 The second class of dyes were probes for the use in membrane 
characterization. A set of new fluorescein and ruthenium ligand complex 
membrane probes were synthesized and purified by chromatic methods, mainly 
by MPLC. The properties of the amphiphilic membrane probes were varied by 
attaching different phospholipid and lipid anchors to the respective 
fluorophore. The dyes were characterized by their absorption and emission 
spectra and their decay times. All dyes show an absorption maximum in the 
range of 480 nm, and are therefore compatible with a 488 nm argon ion laser 
used in clinical routine. 
 
 In chapter 4 the synthesized dyes were evaluated for the use as a 
membrane probe by temperature dependent polarization (a) in glycerin, (b) 
when the dye is embedded in DPPC liposomes and (c) when the membrane 
probe is embedded in DPPC liposomes with different cholesterol 
concentrations. The results show that the ruthenium ligand complex 
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membrane probes are well suited as replacement of the common membrane 
probes of DPH derivatives for measuring membrane dynamics.  
 
 In chapter 5 the ruthenium ligand complex and squarine label were 
tested in the HSA/anti-HSA system using steady-state polarization and 
fluorescence resonance energy transfer for evaluation. A competitive 
homogenous immunoassay was developed for the system HSA/anti-HSA by 
labeling HSA with the MLC label. Additionally, an energy transfer system was 
evaluated, using a ruthenium complex as donor and the squarine label as 
acceptor. The results show that the dyes are well suited for such studies, 
since energy transfer could be detected in the system examined.  
 
 In chapter 6, the influence of the ruthenium label attached to an 
amino functionalized oligonucleotide was investigated in terms of steady-state 
polarization and decay time. To this system the complementary strand labeled 
with the synthesized squarine label was established for energy transfer 
hybridization studies. The location of the dye at the complementary strand 
was investigated to optimize energy transfer.  
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Zusammenfassung 
Diese Arbeit beschreibt zum einen die Synthese bzw. die spektrale 
Charakterisierung von neuen Farbstoffen als Label für HSA und DNA und zum 
anderen die Entwicklung von Ruthenium MLC Membranproben. Die Farbstoffe 
wurden für den Einsatz als Label oder Probe in biologischen Systemen 
evaluiert. 
Kapitel 1 gibt einen kurzen Überblick über die Wichtigkeit von fluoreszenten 
Marker im Lifesciencebereich. Kapitel 2 beschreibt die Methodik der 
Lebenszeitmessung, des Fluoreszenzresonanzenergietransfers und der 
Polarisation. 
 
In Kapitel 3 wird auf die Synthese und spektrale Charakterisierung der 
Farbstoffe eingegangen. Zwei Klassen von Farbstoffen wurden synthetisiert. 
Die erste Klasse von Farbstoffen sind Marker für den Einsatz in Bioassays. Ein 
Ruthenium MLC und ein Squarinefarbstoff wurden für Polarisation- und 
Energietransferstudien synthetisiert. Beide Label konnten durch die NHS/DCC 
Methode in NHS-Ester umgewandelt werden, um sie reaktiv für Aminogruppen 
für ein kovalente Kopplung an Proteine oder Olignucleotide zu machen.  
Die zweite Klasse von Farbstoffen sind Proben zur Charakterisierung von 
Membranen. Eine Reihe von neuen Fluoreszein- und Ruthenium MLC-Proben 
wurden synthetisiert und durch chromatographische Methoden, hauptsächlich 
mittels MPLC, gereinigt. Die Eigenschaften der amphiphilen Membranproben 
erhielt man durch Variation unterschiedlicher Phopholipid- und Lipidanker an 
dem jeweiligen Fluorophor. Die Farbstoffe wurden mittels ihrer Absorptions- 
und Emissionsspektren und ihrer Lebenszeit charakterisiert. Alle Farbstoffe 
zeigten ein breites Absorptionsmaximum nahe 460 nm und sind deshalb 
kompatibel mit einem 488 nm Argonionenlaser, der in der klinischen 
Laborroutine verwendet wird. 
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In Kapitel 4 wurden die synthetisierten Farbstoffe für den Einsatz als 
Membranprobe durch temperaturabhängige Polarisationsmessungen (a) in 
Glycerin, (b) eingebaut in DPPC Liposomen und (c) eingebaut in DPPC 
Liposomen mit verschiedenen Cholesteringehalten, evaluiert. Die Ergebnisse 
zeigten, dass die Ruthenium MLC Membranproben als Ersatz der 
gewöhnlichen DPH-Derivate für die Messung von Membraneigenschaften 
geeignet sind. 
 
In Kapitel 5 wurden die Effekte der Ruthenium MLC- und Squarinelabel im 
System HSA/anti-HSA mittels Polarisation und FRET getestet. Zur 
Entwicklung eines kompetitiven homogenen Immunoassays für das System 
HSA/anti-HSA kam ein mit HSA markierter MLC-Label zum Einsatz. Zusätzlich 
wurde ein Energietransfersystem mit dem MLC Label als Donor und dem 
Squarinelabel als Akzeptor evaluiert. Die Ergebnisse zeigten, dass die 
Farbstoffkombination für die Proteindetektion geeignet ist, da in dem System 
der Effekt des Energietransfers beobachtet werden kann. 
 
Kapitel 6 beschreibt den Einfluß des Rutheniumlabels gebunden an ein 
aminomodifiziertes Oligonucleotid mittels Polarisation und Lebenszeit. Für eine 
Hybridisierungsuntersuchung mittels Energietransfer wurde der 
squaringelabelte Gegenstrang zu diesem System gegeben. Die Variation des 
Abstandes der Farbstoffe and den komplementären Strängen diente der 
Ermittlung des optimalen Energietransfers.  
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